Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000443.4(ABCB4):c.2169dup (p.Leu724fs)	ABCB4	L724fs	Progressive familial intrahepatic cholestasis 3	Pathogenic(Last reviewed: Jan 6, 1998)	no assertion criteria provided	VCV000013694	7	87053263 - 87053264	7	87423947 - 87423948	13694	28733	rs387906529	NC_000007.14:87423947:CCCCCC:CCCCCCC
NC_000003.11:g.(?_128514201)_(128631967_?)dup	ACAD9|CFAP92|LOC112872299|MIR12124|RAB7A		Charcot-Marie-Tooth disease type 2B	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000665056	3	128514201 - 128631967	3	128795358 - 128913124	665056	650966		
NM_001101.5(ACTB):c.474_475dup (p.Val159fs)	ACTB	V159fs	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319337	7	5568238 - 5568239	7	5528607 - 5528608	1319337	1309590		NC_000007.14:5528607:CCCC:CCCCCC
NM_001101.5(ACTB):c.874dup (p.Asp292fs)	ACTB	D292fs	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV001174495	7	5567744 - 5567745	7	5528113 - 5528114	1174495	1163739		NC_000007.14:5528113:C:CC
NM_001101.5(ACTB):c.7_8delinsTT (p.Asp3Phe)	ACTB	D3F	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000968546	7	5569281 - 5569282	7	5529650 - 5529651	968546	955181		NC_000007.14:5529649:TC:AA
NM_001101.5(ACTB):c.616dup (p.Arg206fs)	ACTB	R206fs	Baraitser-Winter syndrome 1	Uncertain significance(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000944265	7	5568097 - 5568098	7	5528466 - 5528467	944265	924877		NC_000007.14:5528466:G:GG
NM_001101.5(ACTB):c.1097dup (p.Ser368fs)	ACTB	S368fs	Baraitser-Winter syndrome 1|Inborn genetic diseases	Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000495294	7	5567409 - 5567410	7	5527778 - 5527779	495294	486791	rs1554329078	NC_000007.14:5527778:CC:CCC
NM_001614.5(ACTG1):c.985-5dup	ACTG1		not specified|Deafness, autosomal dominant 20|Baraitser-Winter Syndrome 2|not provided	Likely benign(Last reviewed: Oct 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000439366	17	79477866	17	81510837 - 81510838	439366	433340	rs782289893	NC_000017.11:81510837:AAA:AAAA
NM_032119.4(ADGRV1):c.955_958dup (p.Leu320fs)	ADGRV1	L320fs	Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000932233	5	89923309 - 89923310	5	90627492 - 90627493	932233	906123		NC_000005.10:90627492:AATC:AATCAATC
NM_032119.4(ADGRV1):c.5779_5783dup (p.Ser1928fs)	ADGRV1	S1928fs	Rare genetic deafness	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000179943	5	89979514 - 89979515	5	90683697 - 90683698	179943	178304	rs730880369	NC_000005.10:90683697:AGACGAG:AGACGAGACGAG
NM_032119.4(ADGRV1):c.2870dup (p.Asn957fs)	ADGRV1	N957fs	Rare genetic deafness	Pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000046309	5	89940652 - 89940653	5	90644835 - 90644836	46309	55474	rs397517429	NC_000005.10:90644835:AAAAAA:AAAAAAA
NM_032119.4(ADGRV1):c.10229_10231dup (p.Val3410dup)	ADGRV1		Rare genetic deafness	Likely pathogenic(Last reviewed: Mar 14, 2011)	no assertion criteria provided	VCV000046245	5	90024551 - 90024552	5	90728734 - 90728735	46245	55410	rs397517418	NC_000005.10:90728734:GTGG:GTGGTGG
NM_001145308.5(LRTOMT):c.614_617dup (p.Ser207fs)	ANAPC15|LRTOMT|TOMT	S167fs, S207fs, S174fs	Deafness, autosomal recessive 63|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 6, 2013)	criteria provided, multiple submitters, no conflicts	VCV000208717	11	71819708 - 71819709	11	72108662 - 72108663	208717	205271	rs797044907	NC_000011.10:72108662:AGCT:AGCTAGCT
NM_001283.5(AP1S1):c.364dup (p.Asp122fs)	AP1S1	D122fs	not provided|Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma	Likely pathogenic(Last reviewed: Apr 15, 2020)	criteria provided, single submitter	VCV000503720	7	100802404 - 100802405	7	101159123 - 101159124	503720	495299	rs767358930	NC_000007.14:101159123:GGGGGGGG:GGGGGGGGG
NM_001004051.4(GPRASP2):c.1717_1718delinsAA (p.Ala573Asn)	ARMCX5-GPRASP2|GPRASP2	A573N	X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000590781	X	101971514 - 101971515	X	102716586 - 102716587	590781	581718	rs1569491884	NC_000023.11:102716585:GC:AA
NM_001692.4(ATP6V1B1):c.1155dup (p.Ile386fs)	ATP6V1B1	I386fs	Renal tubular acidosis with progressive nerve deafness|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000520772	2	71191572 - 71191573	2	70964442 - 70964443	520772	511435	rs781969081	NC_000002.12:70964442:CCCCCCC:CCCCCCCC
NM_001374385.1(ATP8B1):c.2098-21_2098-15dup	ATP8B1|LOC100505549		Progressive familial intrahepatic cholestasis|not provided	Benign/Likely benign(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000327481	18	55335786 - 55335787	18	57668554 - 57668555	327481	347530	rs34422185	NC_000018.10:57668554:AAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAA
NM_001374385.1(ATP8B1):c.2098-20_2098-15dup	ATP8B1|LOC100505549		Progressive familial intrahepatic cholestasis|not provided	Benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000327480	18	55335786 - 55335787	18	57668554 - 57668555	327480	348908	rs34422185	NC_000018.10:57668554:AAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAA
NM_001374385.1(ATP8B1):c.2098-18_2098-15dup	ATP8B1|LOC100505549		Progressive familial intrahepatic cholestasis|not provided	Benign(Last reviewed: Aug 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000327478	18	55335786 - 55335787	18	57668554 - 57668555	327478	331942	rs34422185	NC_000018.10:57668554:AAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAA
NM_001374385.1(ATP8B1):c.2098-17_2098-15dup	ATP8B1|LOC100505549		Progressive familial intrahepatic cholestasis|not provided	Benign/Likely benign(Last reviewed: Aug 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000327477	18	55335786 - 55335787	18	57668554 - 57668555	327477	348905	rs34422185	NC_000018.10:57668554:AAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAA
NM_001374258.1(BRAF):c.2248-28dup	BRAF		Noonan syndrome with multiple lentigines|Noonan syndrome|Cardio-facio-cutaneous syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359047	7	140434597 - 140434598	7	140734797 - 140734798	359047	302001	rs60814637	NC_000007.14:140734797:AAAAAAAAA:AAAAAAAAAA
NM_001374258.1(BRAF):c.2248-27_2248-16delinsTCT	BRAF		Noonan syndrome with multiple lentigines|Cardio-facio-cutaneous syndrome|Noonan syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359046	7	140434586 - 140434597	7	140734786 - 140734797	359046	301998	rs886062016	NC_000007.14:140734785:GAAAAAAAAAAG:AGA
NM_001374258.1(BRAF):c.2248-5dup	BRAF		not specified|not provided|Rasopathy|Cardio-facio-cutaneous syndrome|Noonan syndrome|Noonan syndrome with multiple lentigines	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000044820	7	140434574 - 140434575	7	140734774 - 140734775	44820	53987	rs373442098	NC_000007.14:140734774:AAAAAAAAAAA:AAAAAAAAAAAA
NM_001128840.3(CACNA1D):c.1220+678_1220+679insGGG	CACNA1D		Sinoatrial node dysfunction and deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000039709	3	53707829 - 53707830	3	53673802 - 53673803	39709	48308	rs398122827	NC_000003.12:53673802:GG:GGGGG
NM_053054.4(CATSPER1):c.944_948dup (p.Asp317fs)	CATSPER1	D317fs	Spermatogenic failure 7	Pathogenic(Last reviewed: Mar 23, 2017)	no assertion criteria provided	VCV000004401	11	65792902 - 65792903	11	66025431 - 66025432	4401	19440	rs193929391	NC_000011.10:66025431:GCCATG:GCCATGCCATG
NM_053054.4(CATSPER1):c.539dup (p.His182fs)	CATSPER1	H182fs	Spermatogenic failure 7	Pathogenic(Last reviewed: Mar 23, 2017)	no assertion criteria provided	VCV000004400	11	65793311 - 65793312	11	66025840 - 66025841	4400	19439	rs193929390	NC_000011.10:66025840:A:AA
CCDC50, 8-BP DUP, NT1394	CCDC50		Deafness, autosomal dominant 44	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000001036					1036	16075		
NC_000016.9:g.(?_2098597)_(2550979_?)dup	CCNF|ECI1|DNASE1L2|ABCA3|E4F1|NTN3|PKD1|TSC2|RNPS1|RAB26|TBC1D24|CASKIN1|MLST8|TEDC2|TRAF7|BRICD5|PGP|MIR1225		Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65	Uncertain significance(Last reviewed: Apr 13, 2020)	criteria provided, single submitter	VCV001010653	16	2098597 - 2550979			1010653	986566		
NM_004357.5(CD151):c.382dup (p.Asp128fs)	CD151	D128fs	Nephropathy with pretibial epidermolysis bullosa and deafness	Pathogenic(Last reviewed: Oct 15, 2004)	no assertion criteria provided	VCV000007380	11	837278 - 837279	11	837278 - 837279	7380	22419	rs1565118389	NC_000011.10:837278:GG:GGG
NM_022124.6(CDH23):c.9284dup (p.Arg3096fs)	CDH23	R856fs, R3096fs	not provided|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000623742	10	73571473 - 73571474	10	71811716 - 71811717	623742	612884	rs1564808024	NC_000010.11:71811716:AA:AAA
NM_022124.6(CDH23):c.*117dup	CDH23		Retinitis pigmentosa-deafness syndrome|CDH23-Related Disorders|Nonsyndromic Hearing Loss, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300486	10	73575150 - 73575151	10	71815393 - 71815394	300486	322101	rs886047145	NC_000010.11:71815393:AA:AAA
NM_022124.6(CDH23):c.1949dup (p.Leu651fs)	CDH23	L651fs	Rare genetic deafness	Pathogenic(Last reviewed: Dec 31, 2014)	criteria provided, single submitter	VCV000228328	10	73442286 - 73442287	10	71682529 - 71682530	228328	229858	rs753886326	NC_000010.11:71682529:CCCCCC:CCCCCCC
NM_001039213.4(CEACAM16):c.1122dup (p.Ala375fs)	CEACAM16	A375fs	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000804341	19	45211310 - 45211311	19	44708038 - 44708039	804341	792676	rs1599814534	NC_000019.10:44708038:CCCC:CCCCC
NM_017780.4(CHD7):c.2613+8dup	CHD7		CHARGE association	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001146353	8	61729067 - 61729068	8	60816508 - 60816509	1146353	1139577		NC_000008.11:60816508:A:AA
NM_017780.4(CHD7):c.4850+8_4850+9insATTTTTTTTG	CHD7		CHARGE association	Likely benign(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001095240	8	61754618 - 61754619	8	60842059 - 60842060	1095240	1075500		NC_000008.11:60842059:G:GATTTTTTTTG
NM_017780.4(CHD7):c.2196dup (p.Pro733fs)	CHD7	P733fs	CHARGE association	Pathogenic(Last reviewed: Jun 25, 2020)	criteria provided, single submitter	VCV001072854	8	61707643 - 61707644	8	60795084 - 60795085	1072854	1061379		NC_000008.11:60795084:A:AA
NM_017780.4(CHD7):c.1936dup (p.Arg646fs)	CHD7	R646fs	CHARGE association	Pathogenic(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV001072327	8	61693825 - 61693826	8	60781266 - 60781267	1072327	1061374		NC_000008.11:60781266:AAAA:AAAAA
NM_017780.4(CHD7):c.3695_3710dup (p.Asn1237delinsLysArgTrpSerSerTer)	CHD7		CHARGE association	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001069945	8	61743052 - 61743053	8	60830493 - 60830494	1069945	1061383		NC_000008.11:60830493:GCGGTGGTCAAGCTAA:GCGGTGGTCAAGCTAAGCGGTGGTCAAGCTAA
NM_017780.4(CHD7):c.1953dup (p.Asp652fs)	CHD7	D652fs	CHARGE association	Pathogenic(Last reviewed: Aug 8, 2015)	criteria provided, single submitter	VCV001069874	8	61693839 - 61693840	8	60781280 - 60781281	1069874	1061375		NC_000008.11:60781280:AAAAAAA:AAAAAAAA
NM_017780.4(CHD7):c.1984_1985insGGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCACGAGGTCAGGAGATCGAGACCATCCCGGNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAAAGAACCCAAGGAGA (p.Lys662fs)	CHD7	K662fs	CHARGE association	Pathogenic(Last reviewed: Mar 19, 2020)	criteria provided, single submitter	VCV001068670	8	61693861 - 61693862	8	60781302 - 60781303	1068670	1061376		
NM_017780.4(CHD7):c.6730_6733dup (p.Leu2245fs)	CHD7	L2245fs	CHARGE association	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV001068615	8	61766013 - 61766014	8	60853454 - 60853455	1068615	1061388		NC_000008.11:60853454:AAGC:AAGCAAGC
NM_017780.4(CHD7):c.8538_8549dup (p.Lys2846_Glu2849dup)	CHD7		CHARGE association	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001052427	8	61778030 - 61778031	8	60865471 - 60865472	1052427	1045641		NC_000008.11:60865471:GAGAAAGGAAATGAGAA:GAGAAAGGAAATGAGAAAGGAAATGAGAA
NM_017780.4(CHD7):c.481_482delinsAG (p.Gln161Arg)	CHD7	Q161R	CHARGE association	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001051449	8	61654472 - 61654473	8	60741913 - 60741914	1051449	1045615		NC_000008.11:60741912:CA:AG
NC_000008.10:g.(?_61653972)_(61655676_?)dup	CHD7		CHARGE association	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001011635	8	61653972 - 61655676			1011635	986385		
NM_017780.4(CHD7):c.3237_3238insTAC (p.Ile1080_Ile1081insTyr)	CHD7		CHARGE association	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001002588	8	61736433 - 61736434	8	60823874 - 60823875	1002588	992893		NC_000008.11:60823874:C:CTAC
NM_017780.4(CHD7):c.395_400delinsCAA (p.Glu132_His134delinsAlaAsn)	CHD7		CHARGE association	Uncertain significance(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000970874	8	61654386 - 61654391	8	60741827 - 60741832	970874	955469		NC_000008.11:60741826:AGAGGC:CAA
NM_017780.4(CHD7):c.3372_3373delinsAT (p.Met1124_Asp1125delinsIleTyr)	CHD7		CHARGE association	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000953632	8	61736569 - 61736570	8	60824010 - 60824011	953632	946147		NC_000008.11:60824009:GG:AT
NM_017780.4(CHD7):c.7977_8063delinsCTCA (p.Gly2660fs)	CHD7	G2660fs, G611fs	CHARGE association	Pathogenic(Last reviewed: Jul 27, 2019)	criteria provided, single submitter	VCV000950894	8	61775112 - 61775198	8	60862553 - 60862639	950894	925252		
NM_017780.4(CHD7):c.8068_8069insTAAC (p.Lys2690fs)	CHD7	K641fs, K2690fs	CHARGE association	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000943111	8	61775203 - 61775204	8	60862644 - 60862645	943111	934392		NC_000008.11:60862644::TAAC
NM_017780.4(CHD7):c.2767dup (p.Asp923fs)	CHD7	D923fs	CHARGE association	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000933573	8	61734416 - 61734417	8	60821857 - 60821858	933573	934380		NC_000008.11:60821857:GG:GGG
NM_017780.4(CHD7):c.1496_1497delinsGC (p.Gln499Arg)	CHD7	Q499R	CHARGE association	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000860025	8	61655487 - 61655488	8	60742928 - 60742929	860025	834936		NC_000008.11:60742927:AA:GC
NM_017780.4(CHD7):c.7240_7241delinsTT (p.Ala2414Phe)	CHD7	A2414F	CHARGE association	Uncertain significance(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV000840509	8	61769079 - 61769080	8	60856520 - 60856521	840509	834972		NC_000008.11:60856519:GC:TT
NC_000008.11:g.(?_60741413)_(60865953_?)dup	CHD7		CHARGE association	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000833045	8	61653972 - 61778512			833045	819972		
NC_000008.11:g.(?_60741413)_(60856908_?)dup	CHD7		CHARGE association	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000832837	8	61653972 - 61769467			832837	819971		
NM_017780.4(CHD7):c.7540_7541dup (p.Arg2515fs)	CHD7	R2515fs	CHARGE association	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000692003	8	61769376 - 61769377	8	60856817 - 60856818	692003	679763	rs1586453824	NC_000008.11:60856817:GGGG:GGGGGG
NM_017780.4(CHD7):c.2195dup (p.Pro733fs)	CHD7	P733fs	CHARGE association	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000657791	8	61707638 - 61707639	8	60795079 - 60795080	657791	637318	rs1586341138	NC_000008.11:60795079:CCCCC:CCCCCC
NM_017780.4(CHD7):c.2710dup (p.Tyr904fs)	CHD7	Y904fs	CHARGE association	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000655446	8	61734360 - 61734361	8	60821801 - 60821802	655446	637323	rs1586389310	NC_000008.11:60821801:T:TT
NM_017780.4(CHD7):c.7356_7357dup (p.Ser2453fs)	CHD7	S2453fs	CHARGE association	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000642853	8	61769194 - 61769195	8	60856635 - 60856636	642853	637345	rs1586453329	NC_000008.11:60856635:AA:AAAA
NM_017780.4(CHD7):c.2147_2148delinsTT (p.Lys716Ile)	CHD7	K716I	not provided|CHARGE association	Uncertain significance(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000581127	8	61707595 - 61707596	8	60795036 - 60795037	581127	562478	rs1563606900	NC_000008.11:60795035:AG:TT
NM_017780.4(CHD7):c.2229_2230insCC (p.Gly744fs)	CHD7	G744fs	CHARGE association	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000579768	8	61707677 - 61707678	8	60795118 - 60795119	579768	568022	rs1563607193	NC_000008.11:60795118::CC
NM_017780.4(CHD7):c.4494dup (p.Thr1499fs)	CHD7	T1499fs	CHARGE association	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000572561	8	61750773 - 61750774	8	60838214 - 60838215	572561	562994	rs1563645417	NC_000008.11:60838214:TT:TTT
NM_017780.4(CHD7):c.8744dup (p.Leu2916fs)	CHD7	L867fs, L2916fs	CHARGE association	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547198	8	61778236 - 61778237	8	60865677 - 60865678	547198	537838	rs1554607313	NC_000008.11:60865677:GGGGGG:GGGGGGG
NM_017780.4(CHD7):c.1597_1598insT (p.His533fs)	CHD7	H533fs	CHARGE association	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547191	8	61655588 - 61655589	8	60743029 - 60743030	547191	537831	rs1554581814	NC_000008.11:60743029::T
NM_017780.4(CHD7):c.6989_6990delinsCT (p.Gly2330Ala)	CHD7	G2330A	CHARGE association|not specified|not provided	Benign/Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000529148	8	61768586 - 61768587	8	60856027 - 60856028	529148	524262	rs1554604771	NC_000008.11:60856026:GC:CT
NM_017780.4(CHD7):c.6841_6842insTA (p.Asp2281fs)	CHD7	D2281fs	CHARGE association	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000459561	8	61766987 - 61766988	8	60854428 - 60854429	459561	458572	rs1554604441	NC_000008.11:60854428::TA
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCGGCGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363431	8	61591350	8	60678791	363431	309564	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCGGCGGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363430	8	61591350	8	60678791	363430	309551	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCGGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363429	8	61591350	8	60678791	363429	309550	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363428	8	61591350	8	60678791	363428	314860	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCGGCAGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363427	8	61591350	8	60678791	363427	314912	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCGGCAGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCGGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363426	8	61591350	8	60678791	363426	314911	rs886063026	NC_000008.11:60678790:A:GGCGGCGGCG
NM_017780.4(CHD7):c.-466delinsGGCGGCAGCG	CHD7		Hypogonadism with anosmia|CHARGE association	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363425	8	61591350	8	60678791	363425	314854	rs886063026	NC_000008.11:60678790:A:GGCGGCAGCG
NM_017780.4(CHD7):c.-467_-466insGGCAGC	CHD7		CHARGE association|Hypogonadism with anosmia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363424	8	61591347 - 61591348	8	60678788 - 60678789	363424	309530	rs1554568913	NC_000008.11:60678788:GC:GCGGCAGC
NM_017780.4(CHD7):c.8962dup (p.Asp2988fs)	CHD7	D2988fs, D939fs	Inborn genetic diseases|CHARGE association	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267440	8	61778453 - 61778454	8	60865894 - 60865895	267440	262666	rs771806027	NC_000008.11:60865894:GGGGGGG:GGGGGGGG
NM_017780.4(CHD7):c.7802dup (p.Tyr2601Ter)	CHD7	Y2601*	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267438	8	61773655 - 61773656	8	60861096 - 60861097	267438	262663	rs886040998	NC_000008.11:60861096:A:AA
NM_017780.4(CHD7):c.7282dup (p.Arg2428fs)	CHD7	R2428fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267437	8	61769120 - 61769121	8	60856561 - 60856562	267437	262662	rs886040997	NC_000008.11:60856561:C:CC
NM_017780.4(CHD7):c.5235_5236dup (p.Tyr1746fs)	CHD7	Y1746fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267433	8	61761096 - 61761097	8	60848537 - 60848538	267433	262658	rs886040994	NC_000008.11:60848537:TGT:TGTGT
NM_017780.4(CHD7):c.3674dup (p.Asn1225fs)	CHD7	N1225fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267428	8	61743030 - 61743031	8	60830471 - 60830472	267428	262653	rs886040989	NC_000008.11:60830471:AA:AAA
NM_017780.4(CHD7):c.3071dup (p.Leu1025fs)	CHD7	L1025fs	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267422	8	61735171 - 61735172	8	60822612 - 60822613	267422	262647	rs886040984	NC_000008.11:60822612:CCCC:CCCCC
NM_017780.4(CHD7):c.2376+43_2376+48dup	CHD7		not provided|Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association|not specified	Benign/Likely benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260894	8	61713126 - 61713127	8	60800567 - 60800568	260894	253153	rs5891777	NC_000008.11:60800567:TGGACT:TGGACTTGGACT
NM_017780.4(CHD7):c.7940_7941dup (p.Pro2648fs)	CHD7	P2648fs, P599fs	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210726	8	61774862 - 61774863	8	60862303 - 60862304	210726	207563	rs797045473	NC_000008.11:60862303:GTG:GTGTG
NM_017780.4(CHD7):c.6825dup (p.Met2276fs)	CHD7	M2276fs	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210724	8	61766969 - 61766970	8	60854410 - 60854411	210724	207562	rs797045472	NC_000008.11:60854410:CC:CCC
NM_017780.4(CHD7):c.5638dup (p.Glu1880fs)	CHD7	E1880fs	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210721	8	61763849 - 61763850	8	60851290 - 60851291	210721	207559	rs797045469	NC_000008.11:60851290:GG:GGG
NM_017780.4(CHD7):c.528dup (p.Pro177fs)	CHD7	P177fs	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210720	8	61654515 - 61654516	8	60741956 - 60741957	210720	207549	rs797045468	NC_000008.11:60741956:GGGG:GGGGG
NM_017780.4(CHD7):c.2642dup (p.Tyr881Ter)	CHD7	Y881*	CHARGE association	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210716	8	61732593 - 61732594	8	60820034 - 60820035	210716	207555	rs797045465	NC_000008.11:60820034:A:AA
NM_017780.4(CHD7):c.2502_2509dup (p.His837fs)	CHD7	H837fs	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210714	8	61728946 - 61728947	8	60816387 - 60816388	210714	207553	rs797045463	NC_000008.11:60816387:TCTTATCTTC:TCTTATCTTCTTATCTTC
NM_017780.4(CHD7):c.1678dup (p.Glu560fs)	CHD7	E560fs	CHARGE association	Pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	VCV000210712	8	61693569 - 61693570	8	60781010 - 60781011	210712	207551	rs797045461	NC_000008.11:60781010:GG:GGG
NM_017780.4(CHD7):c.1488dup (p.Pro497fs)	CHD7	P497fs	CHARGE association	Pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	VCV000188297	8	61655478 - 61655479	8	60742919 - 60742920	188297	186090	rs786204200	NC_000008.11:60742919:A:AA
NM_017780.4(CHD7):c.2377-3dup	CHD7		CHARGE association|not provided|History of neurodevelopmental disorder|not specified	Benign/Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000166861	8	61714075 - 61714076	8	60801516 - 60801517	166861	177589	rs752271550	NC_000008.11:60801516:TTTTTTTTT:TTTTTTTTTT
NM_017780.4(CHD7):c.2053_2058dup (p.Ala685_Lys686dup)	CHD7		Hypogonadism with anosmia|not specified|History of neurodevelopmental disorder|not provided|CHARGE association	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095776	8	61693942 - 61693943	8	60781383 - 60781384	95776	101673	rs377139749	NC_000008.11:60781383:AAAGCAAAA:AAAGCAAAAGCAAAA
NM_017780.4(CHD7):c.8682_8683insT (p.Leu2895fs)	CHD7	L846fs, L2895fs	CHARGE association	Pathogenic(Last reviewed: Nov 15, 2007)	no assertion criteria provided	VCV000002037	8	61778180 - 61778181	8	60865621 - 60865622	2037	17076	rs1563674576	NC_000008.11:60865621::T
NM_017780.4(CHD7):c.5752dup (p.Thr1918fs)	CHD7	T1918fs	CHARGE association	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000002029	8	61764663 - 61764664	8	60852104 - 60852105	2029	17068	rs786200873	NC_000008.11:60852104:A:AA
NM_001146079.2(CLDN14):c.40_41insTGGTGCACGGCCGTGCA (p.Ser14fs)	CLDN14	S14fs	Sensorineural hearing loss	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV000984395	21	37833953 - 37833954	21	36461655 - 36461656	984395	972474		NC_000021.9:36461655:TG:TGCACGGCCGTGCACCATG
NM_020982.4(CLDN9):c.500dup (p.Trp168fs)	CLDN9	W168fs	Pendred syndrome	Uncertain significance(Last reviewed: Apr 12, 2021)	criteria provided, single submitter	VCV001064901	16	3063860 - 3063861	16	3013859 - 3013860	1064901	1053364		NC_000016.10:3013859:GGG:GGGG
NM_020982.4(CLDN9):c.370_372dup (p.Ile124dup)	CLDN9		Hearing loss|Deafness, autosomal recessive 116	Pathogenic/Likely pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV000977488	16	3063730 - 3063731	16	3013729 - 3013730	977488	965617		NC_000016.10:3013729:TCATC:TCATCATC
NM_174878.3(CLRN1):c.149_152delinsTGTCCAAT (p.Ser50fs)	CLRN1	S50fs	Rare genetic deafness|Retinal dystrophy|not provided|Usher Syndrome, Type III	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188726	3	150690344 - 150690347	3	150972557 - 150972560	188726	186676	rs786204428	NC_000003.12:150972556:CCTG:ATTGGACA
NM_004086.3(COCH):c.984_985dup (p.Phe329fs)	COCH|LOC100506071	F329fs, F394fs	Deafness, autosomal recessive 110	Pathogenic(Last reviewed: Sep 2, 2019)	no assertion criteria provided	VCV000870100	14	31355023 - 31355024	14	30885817 - 30885818	870100	858272		NC_000014.9:30885817:TCT:TCTCT
NM_001854.4(COL11A1):c.3817-25dup	COL11A1		not provided|not specified|Stickler syndrome type 2|Marshall syndrome|Fibrochondrogenesis 1|Deafness, autosomal dominant 37	Benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000516177	1	103380379 - 103380380	1	102914823 - 102914824	516177	497941	rs34228277	NC_000001.11:102914823:AAAAAAAAAAAAA:AAAAAAAAAAAAAA
NM_001854.4(COL11A1):c.-231dup	COL11A1		Stickler Syndrome, Dominant|Fibrochondrogenesis 1|Marshall syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291560	1	103573964 - 103573965	1	103108408 - 103108409	291560	275732	rs886044983	NC_000001.11:103108408:G:GG
NM_001854.4(COL11A1):c.652-7_652-6dup	COL11A1		not specified|Stickler Syndrome, Dominant|Fibrochondrogenesis 1|Marshall syndrome|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291545	1	103496805 - 103496806	1	103031249 - 103031250	291545	275740	rs36076089	NC_000001.11:103031249:AAAAAAAAAAAAA:AAAAAAAAAAAAAAA
NM_001854.4(COL11A1):c.3817-14_3817-13dup	COL11A1		Marshall syndrome|Stickler Syndrome, Dominant|not specified|Fibrochondrogenesis 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000291508	1	103380379 - 103380380	1	102914823 - 102914824	291508	275676	rs34228277	NC_000001.11:102914823:AAAAAAAAAAAAA:AAAAAAAAAAAAAAA
NM_001854.4(COL11A1):c.4303-13dup	COL11A1		Marshall syndrome|not provided|Stickler Syndrome, Dominant|Fibrochondrogenesis 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000291503	1	103356072 - 103356073	1	102890516 - 102890517	291503	275690	rs35232764	NC_000001.11:102890516:AAAAAAAAAA:AAAAAAAAAAA
NM_001854.4(COL11A1):c.4357-16dup	COL11A1		Marshall syndrome|Stickler Syndrome, Dominant|Fibrochondrogenesis 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291502	1	103355133 - 103355134	1	102889577 - 102889578	291502	275681	rs748850423	NC_000001.11:102889577:AAAAAAAA:AAAAAAAAA
NM_001854.4(COL11A1):c.*628dup	COL11A1		Marshall syndrome|Stickler Syndrome, Dominant|Fibrochondrogenesis 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291485	1	103342946 - 103342947	1	102877390 - 102877391	291485	275654	rs532806397	NC_000001.11:102877390:T:TT
NM_001854.4(COL11A1):c.652-6dup	COL11A1		Stickler Syndrome, Dominant|not specified|Fibrochondrogenesis 1|Marshall syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 26, 2020)	criteria provided, conflicting interpretations	VCV000197736	1	103496805 - 103496806	1	103031249 - 103031250	197736	194897	rs36076089	NC_000001.11:103031249:AAAAAAAAAAAAA:AAAAAAAAAAAAAA
COL11A1, 1-BP INS, 3816T	COL11A1		Marshall syndrome	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000017136					17136	32175		
NM_080680.3(COL11A2):c.968dup (p.Ala324fs)	COL11A2	A324fs	Deafness, autosomal recessive 53	Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813820	6	33152072 - 33152073	6	33184295 - 33184296	813820	802073	rs1583366400	NC_000006.12:33184295:G:GG
NM_000091.5(COL4A3):c.2417dup (p.Gly807fs)	COL4A3|MFF-DT	G807fs	Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552236	2	228145646 - 228145647	2	227280930 - 227280931	552236	542157	rs1440033157	NC_000002.12:227280930:CCCCC:CCCCCC
NM_000091.5(COL4A3):c.2621_2622delinsT (p.Gly874fs)	COL4A3|MFF-DT	G874fs	Alport syndrome, autosomal recessive|not provided	Pathogenic(Last reviewed: Apr 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551951	2	228147213 - 228147214	2	227282497 - 227282498	551951	542030	rs1553760257	NC_000002.12:227282496:GA:T
NM_000091.5(COL4A3):c.833dup (p.Pro279fs)	COL4A3|MFF-DT	P279fs	Benign familial hematuria|Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225321	2	228119375 - 228119376	2	227254659 - 227254660	225321	227238	rs1363680371	NC_000002.12:227254659:T:TT
COL4A3, ALU INS, EX6	COL4A3		Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000017488					17488	32527		
NM_000092.5(COL4A4):c.2312dup (p.Arg773fs)	COL4A4	R773fs	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000974515	2	227924191 - 227924192	2	227059475 - 227059476	974515	962679		NC_000002.12:227059475:CCC:CCCC
NM_000092.5(COL4A4):c.2940dup (p.Gly981fs)	COL4A4	G981fs	Alport syndrome, autosomal recessive	Likely pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV000870370	2	227917048 - 227917049	2	227052332 - 227052333	870370	858523		NC_000002.12:227052332:A:AA
NM_000092.4(COL4A4):c.3861delinsCTC (p.Arg1288fs)	COL4A4		Alport syndrome, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000634651	2	227895271	2	227030555	634651	622522	rs1575895541	NC_000002.12:227030554:C:GAG
NM_000092.5(COL4A4):c.2279dup (p.Asp761fs)	COL4A4	D761fs	Alport syndrome, autosomal recessive|not provided|Benign familial hematuria	Pathogenic/Likely pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555669	2	227924224 - 227924225	2	227059508 - 227059509	555669	541843	rs1553643669	NC_000002.12:227059508:CCC:CCCC
NM_000092.5(COL4A4):c.2628_2654dup (p.Arg877_Gly885dup)	COL4A4		not provided|Alport syndrome, autosomal recessive	Uncertain significance(Last reviewed: Sep 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000422936	2	227920722 - 227920723	2	227056006 - 227056007	422936	405642	rs1553641597	NC_000002.12:227056006:CCTGGGGGACCATGTGCCCCAGGCCGTCCTGGG:CCTGGGGGACCATGTGCCCCAGGCCGTCCTGGGGGACCATGTGCCCCAGGCCGTCCTGGG
NM_033380.3(COL4A5):c.4628dup (p.Tyr1543Ter)	COL4A5	Y1537*, Y1543*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 4, 2021)	criteria provided, single submitter	VCV001213982	X	107936076 - 107936077	X	108692846 - 108692847	1213982	1203975		NC_000023.11:108692846:A:AA
NM_033380.3(COL4A5):c.4978_4979insAAAA (p.Val1660fs)	COL4A5	V1654fs, V1660fs	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV001077042	X	107938653 - 107938654	X	108695423 - 108695424	1077042	1065710		NC_000023.11:108695423::AAAA
NM_033380.3(COL4A5):c.4197_4200delinsGGG (p.Pro1401fs)	COL4A5	P1401fs, P1395fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 18, 2019)	no assertion criteria provided	VCV000829907	X	107925099 - 107925102	X	108681869 - 108681872	829907	818364	rs1603318154	NC_000023.11:108681868:AGGA:GGG
NM_033380.3(COL4A5):c.2300dup (p.Lys768fs)	COL4A5	K768fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000807577	X	107850024 - 107850025	X	108606794 - 108606795	807577	798791	rs1603293553	NC_000023.11:108606794:TTT:TTTT
NM_033380.3(COL4A5):c.4389dup (p.Val1464fs)	COL4A5	V1464fs, V1458fs	Alport syndrome 1, X-linked recessive	Likely pathogenic	no assertion criteria provided	VCV000623486	X	107930784 - 107930785	X	108687554 - 108687555	623486	612448	rs1569508360	NC_000023.11:108687554:T:TT
NM_033380.3(COL4A5):c.2802dup (p.Gly935fs)	COL4A5	G935fs	Alport syndrome 1, X-linked recessive	Likely pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, single submitter	VCV000587295	X	107865939 - 107865940	X	108622709 - 108622710	587295	578192	rs104886368	NC_000023.11:108622709:T:TT
NM_033380.3(COL4A5):c.546+2dup	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2020)	criteria provided, conflicting interpretations	VCV000562420	X	107816885 - 107816886	X	108573655 - 108573656	562420	553604	rs1569489353	NC_000023.11:108573655:T:TT
NM_033380.3(COL4A5):c.-25_-8dup	COL4A5		Alport syndrome 1, X-linked recessive|not provided	Uncertain significance(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000451163	X	107683329 - 107683330	X	108440099 - 108440100	451163	446461	rs752443408	NC_000023.11:108440099:GAAGGAGCTGCGGGAGCCG:GAAGGAGCTGCGGGAGCCGAAGGAGCTGCGGGAGCCG
NM_033380.3(COL4A5):c.3487_3488delinsG (p.Pro1163fs)	COL4A5	P1163fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000369940	X	107909758 - 107909759	X	108666528 - 108666529	369940	354184	rs1057516187	NC_000023.11:108666527:CC:G
NM_033380.3(COL4A5):c.1376dup (p.Gly460fs)	COL4A5	G460fs	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000024405	X	107834821 - 107834822	X	108591591 - 108591592	24405	35746	rs104886113	NC_000023.11:108591591:CCCCCC:CCCCCCC
COL4A5, 10-15-KB INS, 40-KB DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000010455					10455	25494		
NM_033641.4(COL4A6):c.1952-2785_1952-2784insAGA	COL4A6		Deafness, X-linked 6	Benign(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001301627	X	107426982 - 107426983	X	108183752 - 108183753	1301627	1291912		NC_000023.11:108183752:CT:CTTCT
NC_000013.10:g.(?_20716100)_(21398980_?)dup	CRYL1|EEF1AKMT1|GJA3|GJB2|GJB6|IFT88|IL17D|LOC112163647|MIR4499|XPO4		Hidrotic ectodermal dysplasia syndrome|Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Deafness, autosomal dominant 3b	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000656832	13	20716100 - 21398980	13	20141961 - 20824841	656832	652763		
NM_025000.4(DCAF17):c.322-15dup	DCAF17		not specified|not provided|Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV001169859	2	172305175 - 172305176	2	171448665 - 171448666	1169859	1153880		NC_000002.12:171448665:T:TT
NM_025000.4(DCAF17):c.322-15_322-14insTT	DCAF17		not provided|Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV001152174	2	172305175 - 172305176	2	171448665 - 171448666	1152174	1132464		NC_000002.12:171448665:T:TTT
NM_025000.4(DCAF17):c.1204dup (p.Thr402fs)	DCAF17	T335fs, T402fs	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000957844	2	172334517 - 172334518	2	171478007 - 171478008	957844	942407		NC_000002.12:171478007:A:AA
NM_025000.4(DCAF17):c.732+70dup	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities|not provided	Benign(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000801830	2	172314644 - 172314645	2	171458134 - 171458135	801830	790127	rs58636477	NC_000002.12:171458134:TTTTTTTTTTT:TTTTTTTTTTTT
NM_025000.4(DCAF17):c.270dup (p.Cys91fs)	DCAF17	C91fs	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Likely pathogenic(Last reviewed: Dec 6, 2017)	no assertion criteria provided	VCV000632550	2	172300068 - 172300069	2	171443558 - 171443559	632550	620937	rs879253799	NC_000002.12:171443558:AAAA:AAAAA
NM_025000.4(DCAF17):c.*1258dup	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332286	2	172338872 - 172338873	2	171482362 - 171482363	332286	282838	rs745661005	NC_000002.12:171482362:TTTTTTTTTT:TTTTTTTTTTT
NM_025000.4(DCAF17):c.127-3_127-1delinsAA	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031583	2	172291590 - 172291592	2	171435080 - 171435082	31583	40267	rs1574303761	NC_000002.12:171435079:TAG:AA
NM_016356.5(DCDC2):c.549dup (p.Val184fs)	DCDC2	V184fs	Deafness, autosomal recessive 66|Sclerosing cholangitis, neonatal|Nephronophthisis 19	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804454	6	24301950 - 24301951	6	24301722 - 24301723	804454	792758	rs1581640646	NC_000006.12:24301722:A:AA
NM_016356.5(DCDC2):c.970dup (p.Ala324fs)	DCDC2	A324fs	not provided|Deafness, autosomal recessive 66|Sclerosing cholangitis, neonatal	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000595088	6	24205282 - 24205283	6	24205054 - 24205055	595088	586150	rs774115675	NC_000006.12:24205054:CCCCCC:CCCCCCC
NM_016356.5(DCDC2):c.529dup (p.Ile177fs)	DCDC2	I177fs	not provided|Sclerosing cholangitis, neonatal|Sclerosing cholangitis, neonatal|Deafness, autosomal recessive 66	Pathogenic(Last reviewed: Feb 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000417769	6	24301970 - 24301971	6	24301742 - 24301743	417769	404670	rs904944428	NC_000006.12:24301742:TTTTTT:TTTTTTT
NM_005219.5(DIAPH1):c.1461+20_1461+21delinsAG	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001145038	5	140955776 - 140955777	5	141576209 - 141576210	1145038	1136592		NC_000005.10:141576208:TC:CT
NM_005219.5(DIAPH1):c.1137_1138delinsTT (p.Arg379_Leu380=)	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Likely benign(Last reviewed: Jun 25, 2020)	criteria provided, single submitter	VCV001111728	5	140957817 - 140957818	5	141578250 - 141578251	1111728	1094059		NC_000005.10:141578249:GC:AA
NM_005219.5(DIAPH1):c.3149-7_3149-6insG	DIAPH1		Seizures, cortical blindness, and microcephaly syndrome|Deafness, autosomal dominant 1	Likely benign(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV001093558	5	140907270 - 140907271	5	141527703 - 141527704	1093558	1072451		NC_000005.10:141527703::C
NM_005219.5(DIAPH1):c.108dup (p.Lys37Ter)	DIAPH1	K37*	Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001070912	5	140998373 - 140998374	5	141618806 - 141618807	1070912	1060303		NC_000005.10:141618806:A:AA
NM_005219.5(DIAPH1):c.1838dup (p.Pro614fs)	DIAPH1	P605fs, P614fs	Pendred syndrome	Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, single submitter	VCV001065108	5	140953578 - 140953579	5	141574011 - 141574012	1065108	1053227		NC_000005.10:141574011:GG:GGG
NM_005219.5(DIAPH1):c.3217_3219dup (p.Val1073dup)	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Uncertain significance(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV001045605	5	140907193 - 140907194	5	141527626 - 141527627	1045605	1026422		NC_000005.10:141527626:AACA:AACAACA
NM_005219.5(DIAPH1):c.3206_3207insTTC (p.Glu1070_Arg1071insSer)	DIAPH1		Seizures, cortical blindness, and microcephaly syndrome|Deafness, autosomal dominant 1	Uncertain significance(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000967070	5	140907206 - 140907207	5	141527639 - 141527640	967070	954063		NC_000005.10:141527639::GAA
NM_005219.5(DIAPH1):c.1854_1859dup (p.Pro619_Pro620dup)	DIAPH1		Seizures, cortical blindness, and microcephaly syndrome|Deafness, autosomal dominant 1	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV000963523	5	140953557 - 140953558	5	141573990 - 141573991	963523	944434		NC_000005.10:141573990:GGAGGTGGAGG:GGAGGTGGAGGTGGAGG
NM_005219.5(DIAPH1):c.1852_1860dup (p.Pro618_Pro620dup)	DIAPH1		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome|not provided	Uncertain significance(Last reviewed: Feb 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000665955	5	140953556 - 140953557	5	141573989 - 141573990	665955	633534	rs1562320985	NC_000005.10:141573989:AGGAGGTGGAGGAGG:AGGAGGTGGAGGAGGTGGAGGAGG
NM_001130823.3(DNMT1):c.3458_3466dup (p.Pro1153_Leu1155dup)	DNMT1|SHFL		not provided|Hereditary sensory neuropathy type IE	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000801417	19	10251513 - 10251514	19	10140837 - 10140838	801417	789794	rs1449036579	NC_000019.10:10140837:GCAGCTTGGGCAGCTTG:GCAGCTTGGGCAGCTTGGGCAGCTTG
NM_001130823.3(DNMT1):c.1493-11_1493-9dup	DNMT1		Hereditary sensory neuropathy type IE|not provided	Likely benign(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000727289	19	10265740 - 10265741	19	10155064 - 10155065	727289	745174	rs1599366595	NC_000019.10:10155064:AACA:AACAACA
NM_001130823.3(DNMT1):c.1044-18dup	DNMT1		Dementia, Deafness, and Sensory Neuropathy|Hereditary sensory neuropathy type IE	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2020)	criteria provided, conflicting interpretations	VCV000327913	19	10270746 - 10270747	19	10160070 - 10160071	327913	342499	rs59599980	NC_000019.10:10160070:AAAAAAAAAAA:AAAAAAAAAAAA
NM_001130823.3(DNMT1):c.1518_1520delinsATA (p.Asp506_Pro507delinsGluTyr)	DNMT1		Hereditary sensory neuropathy type IE	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029683	19	10265705 - 10265707	19	10155029 - 10155031	29683	38638	rs199473691	NC_000019.10:10155028:GGA:TAT
NM_014208.3(DSPP):c.368_371delinsAACATATGTTCATCATGGGAAAGAAGAAA (p.Gly123fs)	DSPP	G123fs	not provided|Deafness, autosomal dominant 39, with dentinogenesis imperfecta 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2020)	criteria provided, conflicting interpretations	VCV000834048	4	88533706 - 88533709	4	87612554 - 87612557	834048	822295		NC_000004.12:87612553:GAAT:AACATATGTTCATCATGGGAAAGAAGAAA
NM_001376.5(DYNC1H1):c.12275+12_12275+16dup	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Likely benign(Last reviewed: Aug 28, 2020)	criteria provided, single submitter	VCV001124803	14	102508634 - 102508635	14	102042297 - 102042298	1124803	1123485		NC_000014.9:102042297:TTCTCTT:TTCTCTTCTCTT
NM_001376.5(DYNC1H1):c.13812+9dup	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Likely benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001100634	14	102516542 - 102516543	14	102050205 - 102050206	1100634	1102035		NC_000014.9:102050205:GG:GGG
NC_000014.8:g.(?_102492901)_(102516910_?)dup	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001003422	14	102492901 - 102516910			1003422	986514		
NM_001376.5(DYNC1H1):c.519-3dup	DYNC1H1		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000917266	14	102446048 - 102446049	14	101979711 - 101979712	917266	905685		NC_000014.9:101979711:TTTTT:TTTTTT
NM_001376.5(DYNC1H1):c.8638-7dup	DYNC1H1		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916965	14	102492897 - 102492898	14	102026560 - 102026561	916965	905691		NC_000014.9:102026560:TTTTTTT:TTTTTTTT
NM_001376.5(DYNC1H1):c.13801_13802delinsGC (p.Lys4601Ala)	DYNC1H1	K4601A	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000843098	14	102516524 - 102516525	14	102050187 - 102050188	843098	841067		NC_000014.9:102050186:AA:GC
NC_000014.9:g.(?_102026564)_(102050573_?)dup	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000832437	14	102492901 - 102516910			832437	820593		
NM_001376.5(DYNC1H1):c.6857+9_6857+10delinsAA	DYNC1H1		not provided|Charcot-Marie-Tooth disease, axonal, type 2O	Likely benign(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000743451	14	102478459 - 102478460	14	102012122 - 102012123	743451	760243	rs1595615156	NC_000014.9:102012121:TC:AA
NM_001376.5(DYNC1H1):c.73_74delinsAA (p.Ala25Lys)	DYNC1H1	A25K	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000666149	14	102431101 - 102431102	14	101964764 - 101964765	666149	642067	rs1595590120	NC_000014.9:101964763:GC:AA
NM_001376.5(DYNC1H1):c.12684+2_12684+5dup	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000665811	14	102510382 - 102510383	14	102044045 - 102044046	665811	652577	rs769593920	NC_000014.9:102044045:GCAAG:GCAAGCAAG
NM_001376.5(DYNC1H1):c.5433_5433+27dup	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000659791	14	102471569 - 102471570	14	102005232 - 102005233	659791	652571	rs1382359405	NC_000014.9:102005232:CTTGGTTAGTCTCACACCTGACTCCTTCCTT:CTTGGTTAGTCTCACACCTGACTCCTTCCTTGGTTAGTCTCACACCTGACTCCTTCCTT
NM_001376.5(DYNC1H1):c.12109_12110delinsTT (p.Pro4037Phe)	DYNC1H1	P4037F	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000658365	14	102508356 - 102508357	14	102042019 - 102042020	658365	642103	rs1595631704	NC_000014.9:102042018:CC:TT
NM_001376.5(DYNC1H1):c.2820dup (p.Asp941fs)	DYNC1H1	D941fs	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000646797	14	102455140 - 102455141	14	101988803 - 101988804	646797	642080	rs1595602265	NC_000014.9:101988803:A:AA
NM_001376.5(DYNC1H1):c.624_625delinsAG (p.Ile209Val)	DYNC1H1	I209V	Charcot-Marie-Tooth disease, axonal, type 2O	Uncertain significance(Last reviewed: Sep 2, 2017)	criteria provided, single submitter	VCV000539762	14	102446161 - 102446162	14	101979824 - 101979825	539762	527842	rs1555407906	NC_000014.9:101979823:GA:AG
NM_001376.5(DYNC1H1):c.962-15dup	DYNC1H1		Charcot-Marie-Tooth disease|not specified|not provided|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Mental retardation, autosomal dominant 13|Charcot-Marie-Tooth disease, axonal, type 2O	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000516950	14	102449338 - 102449339	14	101983001 - 101983002	516950	504324	rs3830914	NC_000014.9:101983001:TTT:TTTT
NM_001376.5(DYNC1H1):c.11461-9_11461-8insG	DYNC1H1		Charcot-Marie-Tooth disease, axonal, type 2O	Likely benign(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000472506	14	102505740 - 102505741	14	102039403 - 102039404	472506	463797	rs762712158	NC_000014.9:102039403::G
NM_001376.5(DYNC1H1):c.5433+17dup	DYNC1H1		not specified|Charcot-Marie-Tooth disease	Benign(Last reviewed: Nov 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000420240	14	102471589 - 102471590	14	102005252 - 102005253	420240	409060	rs140185574	NC_000014.9:102005252:A:AA
NM_000399.5(EGR2):c.1090_1092dup (p.His364dup)	EGR2		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jan 26, 2020)	criteria provided, single submitter	VCV001024981	10	64573305 - 64573306	10	62813545 - 62813546	1024981	1009063		NC_000010.11:62813545:GTGG:GTGGTGG
NM_000399.5(EGR2):c.594_596dup (p.Ser199dup)	EGR2		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000947970	10	64573801 - 64573802	10	62814041 - 62814042	947970	925845		NC_000010.11:62814041:GAGGA:GAGGAGGA
NC_000016.10:g.(?_13821951)_(13937868_?)dup	ERCC4		Fanconi anemia, complementation group Q|Cockayne syndrome|Xeroderma pigmentosum, group F	Uncertain significance(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000830517	16	13915808 - 14031725			830517	820765		
NM_000124.4(ERCC6):c.3481_3482delinsCC (p.Ser1161Pro)	ERCC6	S1161P	Cockayne syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000705820	10	50678524 - 50678525	10	49470478 - 49470479	705820	692846	rs1590405627	NC_000010.11:49470477:CT:GG
NM_000124.4(ERCC6):c.*232dup	ERCC6		Macular degeneration|COFS syndrome|Cockayne syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300029	10	50666628 - 50666629	10	49458582 - 49458583	300029	322302	rs74561842	NC_000010.11:49458582:AAAAAAAAAAAAA:AAAAAAAAAAAAAA
NM_000124.4(ERCC6):c.*1981dup	ERCC6		Cockayne syndrome|Macular degeneration|COFS syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300004	10	50664879 - 50664880	10	49456833 - 49456834	300004	321491	rs557832376	NC_000010.11:49456833:A:AA
NM_000082.4(ERCC8):c.*373_*375dup	ERCC8		Cockayne syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354009	5	60170066 - 60170067	5	60874239 - 60874240	354009	300095	rs886060720	NC_000005.10:60874239:TGAT:TGATGAT
NM_031475.3(ESPN):c.1756dup (p.Ala586fs)	ESPN	A586fs, A556fs	Deafness, autosomal recessive 36, without vestibular involvement	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000004424	1	6508991 - 6508992	1	6448931 - 6448932	4424	19463	rs1569712066	NC_000001.11:6448931:G:GG
NM_001379180.1(ESRRB):c.1011dup (p.Leu338fs)	ESRRB	L317fs, L338fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000505350	14	76957946 - 76957947	14	76491603 - 76491604	505350	497039	rs1555344820	NC_000014.9:76491603:GGGG:GGGGG
ESRRB, 7-BP DUP, NT1018	ESRRB		Deafness, autosomal recessive 35	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007498					7498	22537		
NM_000503.6(EYA1):c.1195dup (p.Leu399fs)	EYA1	L393fs, L399fs, L428fs, L392fs, L277fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000667001	8	72129203 - 72129204	8	71216968 - 71216969	667001	654517	rs1585820240	NC_000008.11:71216968:GG:GGG
NM_000503.6(EYA1):c.1697_1698insT (p.Lys566fs)	EYA1	K444fs, K595fs, K559fs, K560fs, K566fs	Rare genetic deafness	Pathogenic(Last reviewed: Oct 28, 2010)	criteria provided, single submitter	VCV000048104	8	72123391 - 72123392	8	71211156 - 71211157	48104	57268	rs397517919	NC_000008.11:71211156::A
NM_004100.5(EYA4):c.1720_1722delTACinsAAA	EYA4|TARID	Y574K, Y526K, Y551K, Y580K, Y520K	Deafness, autosomal dominant 10	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813822	6	133844297 - 133844299	6	133523159 - 133523161	813822	905062		NC_000006.12:133523158:TAC:AAA
EYA4, 2-BP INS, 1490AA	EYA4		Deafness, autosomal dominant 10	Pathogenic(Last reviewed: Jul 15, 2007)	no assertion criteria provided	VCV000006239					6239	21278		
EYA4, 2-BP INS, 1468AA	EYA4		Deafness, autosomal dominant 10	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006236					6236	21275		
NM_001370298.3(FGD4):c.905dup (p.Leu304fs)	FGD4	L167fs, L74fs, L252fs, L304fs	Charcot-Marie-Tooth disease, type 4H	Likely pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000812029	12	32735294 - 32735295	12	32582360 - 32582361	812029	799679	rs1592294998	NC_000012.12:32582360:T:TT
NM_001370298.3(FGD4):c.925dup (p.Ala309fs)	FGD4	A172fs, A257fs, A79fs, A309fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637079	12	32735311 - 32735312	12	32582377 - 32582378	637079	625276	rs1565869918	NC_000012.12:32582377:GGGG:GGGGG
NM_001370298.3(FGD4):c.2622dup (p.Ala875fs)	FGD4	A554fs, A738fs, A823fs, A645fs, A394fs, A875fs	Charcot-Marie-Tooth disease, type 4H	Pathogenic(Last reviewed: Nov 30, 2018)	no assertion criteria provided	VCV000598939	12	32793376 - 32793377	12	32640442 - 32640443	598939	590026	rs1565942358	NC_000012.12:32640442:A:AA
NM_001370298.3(FGD4):c.1248-16dup	FGD4		Charcot-Marie-Tooth disease|not provided	Likely benign(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418192	12	32755074 - 32755075	12	32602140 - 32602141	418192	408629	rs368420700	NC_000012.12:32602140:TTTTT:TTTTTT
NM_002010.3(FGF9):c.*2463dup	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311468	13	22278024 - 22278025	13	21703885 - 21703886	311468	335623	rs757466207	NC_000013.11:21703885:TTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_002010.3(FGF9):c.-37dup	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311420	13	22246014 - 22246015	13	21671875 - 21671876	311420	327653	rs752566182	NC_000013.11:21671875:A:AA
NM_002010.3(FGF9):c.-116dup	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311418	13	22245935 - 22245936	13	21671796 - 21671797	311418	319167	rs1555223891	NC_000013.11:21671796:C:CC
NM_002010.3(FGF9):c.-118_-117insC	FGF9		Symphalangism-brachydactyly syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311417	13	22245934 - 22245935	13	21671795 - 21671796	311417	335582	rs1555223896	NC_000013.11:21671795::C
NM_002010.3(FGF9):c.-118_-117dup	FGF9		Symphalangism-brachydactyly syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311416	13	22245927 - 22245928	13	21671788 - 21671789	311416	333898	rs10624265	NC_000013.11:21671788:TTTTTTTT:TTTTTTTTTT
NM_002010.3(FGF9):c.-117dup	FGF9		Symphalangism-brachydactyly syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311415	13	22245927 - 22245928	13	21671788 - 21671789	311415	333907	rs10624265	NC_000013.11:21671788:TTTTTTTT:TTTTTTTTT
NM_002010.3(FGF9):c.-585dup	FGF9		Symphalangism-brachydactyly syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000311407	13	22245461 - 22245462	13	21671322 - 21671323	311407	333897	rs886050040	NC_000013.11:21671322:TTTTTT:TTTTTTT
NM_014845.6(FIG4):c.446+32dup	FIG4		Polymicrogyria, bilateral temporooccipital|not provided|Charcot-Marie-Tooth disease|Yunis-Varon syndrome|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11	Benign(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000917314	6	110048489 - 110048490	6	109727286 - 109727287	917314	905582		NC_000006.12:109727286:TTTTTTTTTTT:TTTTTTTTTTTT
NM_014845.6(FIG4):c.447-4_447-3dup	FIG4		not provided|Charcot-Marie-Tooth disease|not specified	Benign/Likely benign(Last reviewed: Aug 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000917084	6	110053824 - 110053825	6	109732621 - 109732622	917084	905585		NC_000006.12:109732621:TTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_014845.6(FIG4):c.447-17dup	FIG4		Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease|not specified	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000917083	6	110053820 - 110053821	6	109732617 - 109732618	917083	905583		NC_000006.12:109732617:TTT:TTTT
NM_014845.6(FIG4):c.2377-20_2377-19insC	FIG4		Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not specified	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000917082	6	110113765 - 110113766	6	109792562 - 109792563	917082	905591		NC_000006.12:109792562::C
NM_014845.6(FIG4):c.447-16delinsTT	FIG4		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000917077	6	110053824	6	109732621	917077	905584		NC_000006.12:109732620:G:TT
NM_014845.6(FIG4):c.2377-20_2377-19insCT	FIG4		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916999	6	110113764 - 110113765	6	109792561 - 109792562	916999	905592		NC_000006.12:109792561:T:TCT
NM_014845.6(FIG4):c.2247dup (p.Ser750fs)	FIG4	S750fs	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000916868	6	110112639 - 110112640	6	109791436 - 109791437	916868	905187		NC_000006.12:109791436:CCCCCC:CCCCCCC
NM_014845.6(FIG4):c.447-3dup	FIG4		Polymicrogyria, bilateral temporooccipital|Yunis-Varon syndrome|not specified|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Benign(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000694980	6	110053824 - 110053825	6	109732621 - 109732622	694980	683117	rs11377100	NC_000006.12:109732621:TTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_014845.6(FIG4):c.1147_1148delinsT (p.Glu382_Lys383insTer)	FIG4		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637526	6	110081462 - 110081463	6	109760259 - 109760260	637526	625131	rs1583695317	NC_000006.12:109760258:AA:T
NM_014845.6(FIG4):c.790_793delinsTTCCAAGAGCTGTT (p.Gly264fs)	FIG4	G264fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637525	6	110062661 - 110062664	6	109741458 - 109741461	637525	625130	rs1583669418	NC_000006.12:109741457:GGAC:TTCCAAGAGCTGTT
NM_014845.6(FIG4):c.2299dup (p.Glu767fs)	FIG4	E767fs	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000637500	6	110112694 - 110112695	6	109791491 - 109791492	637500	625135	rs1191997383	NC_000006.12:109791491:GGG:GGGG
NM_014845.6(FIG4):c.1986dup (p.Lys663fs)	FIG4	K663fs	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV000637086	6	110107541 - 110107542	6	109786338 - 109786339	637086	625134	rs1197741113	NC_000006.12:109786338:G:GG
NM_014845.6(FIG4):c.1149_1150delinsT (p.Lys383fs)	FIG4	K383fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637085	6	110081464 - 110081465	6	109760261 - 109760262	637085	625132	rs1583695328	NC_000006.12:109760260:AA:T
NM_014845.6(FIG4):c.1373dup (p.Leu458fs)	FIG4	L458fs	Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419553	6	110083391 - 110083392	6	109762188 - 109762189	419553	406787	rs770043095	NC_000006.12:109762188:TTTT:TTTTT
NM_001080472.4(FITM2):c.39dup (p.Thr14fs)	FITM2	T14fs	Siddiqi syndrome	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692230	20	42939750	20	44311109 - 44311110	692230	680034	rs1255226703	NC_000020.11:44311109:CCCCC:CCCCCC
NC_000004.12:g.143428960_143495936dup	GAB1		Bilateral sensorineural hearing impairment	Uncertain significance(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV000983425	4	144350113 - 144417089			983425	971381		
NM_001002295.2(GATA3):c.708dup (p.Ser237fs)	GATA3	S237fs	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: May 28, 2020)	criteria provided, single submitter	VCV000977148	10	8100727 - 8100728	10	8058764 - 8058765	977148	965281		NC_000010.11:8058764:CCCCCCC:CCCCCCCC
NM_001002295.2(GATA3):c.*264_*265dup	GATA3		not provided|Hypoparathyroidism, deafness, renal disease syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2019)	criteria provided, conflicting interpretations	VCV000301134	10	8116241 - 8116242	10	8074278 - 8074279	301134	311338	rs3839918	NC_000010.11:8074278:AAAAAAAAAA:AAAAAAAAAAAA
NM_001002295.2(GATA3):c.*265dup	GATA3		Hypoparathyroidism, deafness, renal disease syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 6, 2019)	criteria provided, conflicting interpretations	VCV000301133	10	8116241 - 8116242	10	8074278 - 8074279	301133	322826	rs3839918	NC_000010.11:8074278:AAAAAAAAAA:AAAAAAAAAAA
NM_001002295.2(GATA3):c.-370+28dup	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000301102	10	8096869 - 8096870	10	8054906 - 8054907	301102	316796	rs397846644	NC_000010.11:8054906:TTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_001002295.2(GATA3):c.-503_-502dup	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000301100	10	8096706 - 8096707	10	8054743 - 8054744	301100	311299	rs60098638	NC_000010.11:8054743:AAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAA
NM_001002295.2(GATA3):c.681_682insACCACCCCATCAGCACTCACCCGCCCTACGTGCCC (p.Glu228fs)	GATA3	E228fs	Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236031	10	8100690 - 8100691	10	8058727 - 8058728	236031	237608	rs878853222	NC_000010.11:8058727:ACCCGCCCTACGTGCCC:ACCCGCCCTACGTGCCCACCACCCCATCAGCACTCACCCGCCCTACGTGCCC
NM_001002295.2(GATA3):c.924+2delinsGCTTACTTCCC	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016629	10	8106103	10	8064140	16629	31668	rs387906551	NC_000010.11:8064139:T:GCTTACTTCCC
GATA3, 2-BP INS, 3-BP INS	GATA3		Hypoparathyroidism, deafness, renal disease syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000016625					16625	31664		
NM_018972.4(GDAP1):c.272_274delinsTTT (p.Thr91_Gln92delinsIleTer)	GDAP1		Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000917000	8	75263663 - 75263665	8	74351428 - 74351430	917000	905243		NC_000008.11:74351427:CTC:TTT
NM_018972.4(GDAP1):c.100dup (p.Ser34fs)	GDAP1	S34fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637556	8	75262794 - 75262795	8	74350559 - 74350560	637556	625157	rs1586794271	NC_000008.11:74350559:TT:TTT
NM_018972.4(GDAP1):c.174_176delinsTGTG (p.Pro59fs)	GDAP1	P59fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000637547	8	75263565 - 75263567	8	74351330 - 74351332	637547	625162	rs1586795216	NC_000008.11:74351329:GCC:TGTG
NM_018972.4(GDAP1):c.864dup (p.Phe289fs)	GDAP1	F180fs, F289fs, F221fs, F231fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637455	8	75276388 - 75276389	8	74364153 - 74364154	637455	625189	rs1586807423	NC_000008.11:74364153:A:AA
NM_018972.4(GDAP1):c.172_173delinsTTA (p.Pro59fs)	GDAP1	P59fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637123	8	75263563 - 75263564	8	74351328 - 74351329	637123	625161	rs1586795201	NC_000008.11:74351327:CT:TTA
NM_018972.4(GDAP1):c.349dup (p.Tyr117fs)	GDAP1	Y117fs, Y49fs, Y8fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, recessive intermediate A	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000637122	8	75272409 - 75272410	8	74360174 - 74360175	637122	625167	rs1586803063	NC_000008.11:74360174:T:TT
NM_018972.4(GDAP1):c.1019dup (p.Arg341fs)	GDAP1	R232fs, R283fs, R341fs, R273fs	Inborn genetic diseases|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4A	Conflicting interpretations of pathogenicity(Last reviewed: Feb 29, 2020)	criteria provided, conflicting interpretations	VCV000406140	8	75276540 - 75276541	8	74364305 - 74364306	406140	396688	rs756461496	NC_000008.11:74364305:TTTT:TTTTT
NM_133261.3(GIPC3):c.685dup (p.Ala229fs)	GIPC3	A229fs	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030755	19	3589526 - 3589527	19	3589528 - 3589529	30755	39712	rs748150647	NC_000019.10:3589528:GGGGGGG:GGGGGGGG
NM_000166.6(GJB1):c.141_143dup (p.Lys48dup)	GJB1		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637944	X	70443696 - 70443697	X	71223846 - 71223847	637944	625508	rs1602348833	NC_000023.11:71223846:AGAA:AGAAGAA
NM_000166.6(GJB1):c.761dup (p.Gln255fs)	GJB1	Q255fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637919	X	70444317 - 70444318	X	71224467 - 71224468	637919	625703	rs1602349920	NC_000023.11:71224467:A:AA
NM_000166.6(GJB1):c.210dup (p.Ile71fs)	GJB1	I71fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637918	X	70443763 - 70443764	X	71223913 - 71223914	637918	625530	rs1602348918	NC_000023.11:71223913:CCCC:CCCCC
NM_000166.6(GJB1):c.308dup (p.Lys104fs)	GJB1	K104fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637878	X	70443863 - 70443864	X	71224013 - 71224014	637878	625576	rs1602349159	NC_000023.11:71224013:AA:AAA
NM_000166.6(GJB1):c.114_115insC (p.Ala39fs)	GJB1	A39fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637876	X	70443671 - 70443672	X	71223821 - 71223822	637876	625494	rs1602348767	NC_000023.11:71223821::C
NM_000166.6(GJB1):c.44_45delinsTT (p.Arg15Leu)	GJB1	R15L	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637673	X	70443601 - 70443602	X	71223751 - 71223752	637673	625461	rs1602348605	NC_000023.11:71223750:GG:TT
NM_000166.6(GJB1):c.484dup (p.Met162fs)	GJB1	M162fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637672	X	70444040 - 70444041	X	71224190 - 71224191	637672	625632	rs1602349460	NC_000023.11:71224190:A:AA
NM_000166.6(GJB1):c.436_437delinsAT (p.Glu146Met)	GJB1	E146M	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637659	X	70443993 - 70443994	X	71224143 - 71224144	637659	625607	rs1602349347	NC_000023.11:71224142:GA:AT
NM_000166.6(GJB1):c.641_642delinsAT (p.Ile214Asn)	GJB1	I214N	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637621	X	70444198 - 70444199	X	71224348 - 71224349	637621	625696	rs1602349807	NC_000023.11:71224347:TC:AT
NM_000166.6(GJB1):c.42_43insT (p.Arg15fs)	GJB1	R15fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637607	X	70443599 - 70443600	X	71223749 - 71223750	637607	625460	rs1602348598	NC_000023.11:71223749::T
NM_000166.6(GJB1):c.208_209delinsTT (p.Pro70Phe)	GJB1	P70F	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637606	X	70443765 - 70443766	X	71223915 - 71223916	637606	625532	rs1602348930	NC_000023.11:71223914:CC:TT
NM_000166.6(GJB1):c.338_345delinsTGGC (p.Asp113fs)	GJB1	D113fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637598	X	70443895 - 70443902	X	71224045 - 71224052	637598	625581	rs1602349208	NC_000023.11:71224044:ACCCCCTA:TGGC
NM_000166.6(GJB1):c.533_536dup (p.Cys179Ter)	GJB1	C179*	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637497	X	70444088 - 70444089	X	71224238 - 71224239	637497	625652	rs1602349585	NC_000023.11:71224238:GACTG:GACTGACTG
NM_000166.6(GJB1):c.573_574insTCA (p.Val192_Phe193insSer)	GJB1		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637251	X	70444130 - 70444131	X	71224280 - 71224281	637251	625671	rs1602349684	NC_000023.11:71224280::TCA
NM_000166.6(GJB1):c.617dup (p.Ala207fs)	GJB1	A207fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637222	X	70444173 - 70444174	X	71224323 - 71224324	637222	625688	rs1602349763	NC_000023.11:71224323:T:TT
NM_000166.6(GJB1):c.571dup (p.Thr191fs)	GJB1	T191fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637193	X	70444127 - 70444128	X	71224277 - 71224278	637193	625669	rs1602349676	NC_000023.11:71224277:A:AA
NM_000166.6(GJB1):c.556dup (p.Glu186fs)	GJB1	E186fs	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000637173	X	70444112 - 70444113	X	71224262 - 71224263	637173	625667	rs1602349655	NC_000023.11:71224262:G:GG
NM_000166.6(GJB1):c.844dup (p.Ala282fs)	GJB1	A282fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637167	X	70444399 - 70444400	X	71224549 - 71224550	637167	625714	rs1602350062	NC_000023.11:71224549:GG:GGG
NM_000166.6(GJB1):c.524dup (p.Asn175fs)	GJB1	N175fs	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Feb 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000567945	X	70444079 - 70444080	X	71224229 - 71224230	567945	574883	rs1569215346	NC_000023.11:71224229:AA:AAA
NM_000166.6(GJB1):c.324dup (p.Glu109Ter)	GJB1	E109*	not provided|Charcot-Marie-Tooth disease	Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000503687	X	70443879 - 70443880	X	71224029 - 71224030	503687	495847	rs1555937143	NC_000023.11:71224029:TT:TTT
NM_004004.6(GJB2):c.79_82delinsAGA (p.Val27fs)	GJB2	V27fs	Deafness, autosomal recessive 1A	Pathogenic	criteria provided, single submitter	VCV001202621	13	20763639 - 20763642	13	20189500 - 20189503	1202621	1192629		NC_000013.11:20189499:GGAC:TCT
NM_004004.6(GJB2):c.560_605dup (p.Cys202Ter)	GJB2	C202*	not provided|Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000627447	13	20763115 - 20763116	13	20188976 - 20188977	627447	615817	rs1566528185	NC_000013.11:20188976:CAAATTCCAGACACTGCAATCATGAACACTGTGAAGACAGTCTTCTC:CAAATTCCAGACACTGCAATCATGAACACTGTGAAGACAGTCTTCTCAAATTCCAGACACTGCAATCATGAACACTGTGAAGACAGTCTTCTC
NM_004004.6(GJB2):c.232dup (p.Ala78fs)	GJB2	A78fs	Nonsyndromic hearing loss and deafness|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553568	13	20763488 - 20763489	13	20189349 - 20189350	553568	546940	rs1555341960	NC_000013.11:20189349:CCC:CCCC
NM_004004.6(GJB2):c.239dup (p.Leu81fs)	GJB2	L81fs	not provided|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551879	13	20763481 - 20763482	13	20189342 - 20189343	551879	547319	rs1555341954	NC_000013.11:20189342:T:TT
NM_004004.6(GJB2):c.508_511dup (p.Ala171fs)	GJB2	A171fs	not provided|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189070	13	20763209 - 20763210	13	20189070 - 20189071	189070	186855	rs773528125	NC_000013.11:20189070:CGTT:CGTTCGTT
NM_004004.6(GJB2):c.290dup (p.Tyr97Ter)	GJB2	Y97*	Deafness, autosomal recessive 1A|not provided	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188821	13	20763430 - 20763431	13	20189291 - 20189292	188821	186858	rs786204491	NC_000013.11:20189291:T:TT
NM_004004.6(GJB2):c.269dup (p.Val91fs)	GJB2	V91fs	Rare genetic deafness|Hearing loss|Nonsyndromic Deafness|none provided|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not provided	Pathogenic(Last reviewed: Apr 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000177737	13	20763451 - 20763452	13	20189312 - 20189313	177737	175904	rs730880338	NC_000013.11:20189312:A:AA
NM_004004.6(GJB2):c.35dup (p.Val13fs)	GJB2	V13fs	Hearing impairment|Rare genetic deafness|not provided|Deafness, autosomal recessive 1A|Hearing loss	Conflicting interpretations of pathogenicity(Last reviewed: Jun 8, 2021)	criteria provided, conflicting interpretations	VCV000094392	13	20763685 - 20763686	13	20189546 - 20189547	94392	100292	rs80338939	NC_000013.11:20189546:CCCCCC:CCCCCCC
NM_004004.6(GJB2):c.592_600delinsCAGTGTTCATGACATTC (p.Val198_Gly200delinsGlnCysSerTer)	GJB2		Hearing loss|not provided|Rare genetic deafness|Deafness, autosomal recessive 1A	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044761	13	20763121 - 20763129	13	20188982 - 20188990	44761	53928	rs111033335	NC_000013.11:20188981:TCCAGACAC:GAATGTCATGAACACTG
NM_004004.6(GJB2):c.280_284dup (p.Ala96fs)	GJB2	A96fs	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Sep 15, 2002)	no assertion criteria provided	VCV000017025	13	20763436 - 20763437	13	20189297 - 20189298	17025	32064	rs886037625	NC_000013.11:20189297:ACGTG:ACGTGACGTG
NM_004004.6(GJB2):c.51_62delinsA (p.Thr18fs)	GJB2	T18fs	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000017013	13	20763659 - 20763670	13	20189520 - 20189531	17013	32052	rs886037624	NC_000013.11:20189519:CCAATGCTGGTG:T
NM_000404.4(GLB1):c.793-14dup	GLB1		Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001166391	3	33093503 - 33093504	3	33052011 - 33052012	1166391	1154461		NC_000003.12:33052011:AAAAAAA:AAAAAAAA
NM_000404.4(GLB1):c.1735-16_1735-9dup	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Likely benign(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV001092402	3	33038844 - 33038845	3	32997352 - 32997353	1092402	1070686		NC_000003.12:32997352:AGAGAGACAGAGA:AGAGAGACAGAGAGACAGAGA
NM_000404.4(GLB1):c.2006dup (p.Asn669fs)	GLB1	N538fs, N639fs, N669fs, N717fs	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001067823	3	33038564 - 33038565	3	32997072 - 32997073	1067823	1055331		NC_000003.12:32997072:TTTTTTT:TTTTTTTT
NM_000404.4(GLB1):c.1685dup (p.Asp564fs)	GLB1	D433fs, D612fs, D534fs, D564fs	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000959418	3	33055596 - 33055597	3	33014104 - 33014105	959418	943476		NC_000003.12:33014104:A:AA
NM_000404.4(GLB1):c.900_903dup (p.Ser302fs)	GLB1	S171fs, S272fs, S302fs, S350fs	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000948954	3	33093385 - 33093386	3	33051893 - 33051894	948954	923139		NC_000003.12:33051893:CGCCC:CGCCCGCCC
NM_000404.4(GLB1):c.817_818delinsCT (p.Trp273Leu)	GLB1	W273L, W142L, W243L, W321L	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000568792	3	33093471 - 33093472	3	33051979 - 33051980	568792	559427	rs1559401428	NC_000003.12:33051978:CA:AG
NM_000404.4(GLB1):c.694dup (p.Ala232fs)	GLB1	A280fs, A202fs, A232fs	GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552535	3	33099619 - 33099620	3	33058127 - 33058128	552535	543117	rs1553611025	NC_000003.12:33058127:CCCC:CCCCC
NM_000404.4(GLB1):c.1634dup (p.Asn545fs)	GLB1	N593fs, N414fs, N515fs, N545fs	GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550413	3	33055647 - 33055648	3	33014155 - 33014156	550413	543109	rs754131566	NC_000003.12:33014155:TT:TTT
NM_000404.4(GLB1):c.1577dup (p.Trp527fs)	GLB1	W527fs, W575fs, W497fs, W396fs	not provided|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|GLB1-Related Disorders	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000202191	3	33055704 - 33055705	3	33014212 - 33014213	202191	198618	rs794729217	NC_000003.12:33014212:CCCCCC:CCCCCCC
NM_000404.4(GLB1):c.1456_1466dup (p.Ile489fs)	GLB1	I459fs, I489fs, I358fs, I537fs	not provided|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092898	3	33058213 - 33058214	3	33016721 - 33016722	92898	98805	rs398123349	NC_000003.12:33016721:ATATATGCACCATA:ATATATGCACCATATATGCACCATA
NM_000404.4(GLB1):c.75+2dup	GLB1|TMPPE		not provided|GM1 gangliosidosis type 3|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000936	3	33138500 - 33138501	3	33097008 - 33097009	936	15975	rs587776525	NC_000003.12:33097008:A:AA
NM_000404.4(GLB1):c.256_278dup (p.Gln95fs)	GLB1	Q143fs, Q65fs, Q95fs	Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000000934	3	33110429 - 33110430	3	33068937 - 33068938	934	15973	rs587776524	NC_000003.12:33068937:GGCCAGGGCTCATGAAAGTTCCAGG:GGCCAGGGCTCATGAAAGTTCCAGGCCAGGGCTCATGAAAGTTCCAGG
NM_000404.2(GLB1):c.1069_1233dup	GLB1		Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000000927					927	15966		
NM_013296.5(GPSM2):c.858_859delinsGT (p.Tyr286_Ser287delinsTer)	GPSM2		Chudley-McCullough syndrome	Likely pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, single submitter	VCV001064650	1	109444472 - 109444473	1	108901850 - 108901851	1064650	1052898		NC_000001.11:108901849:CA:GT
NM_024915.4(GRHL2):c.1609dup (p.Arg537fs)	GRHL2	R521fs, R537fs	Deafness, autosomal dominant 28	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000002195	8	102656449 - 102656450	8	101644221 - 101644222	2195	17234	rs398122997	NC_000008.11:101644221:C:CC
NM_001080516.2(GRXCR2):c.714dup (p.Gly239fs)	GRXCR2	G239fs	Deafness, autosomal recessive 101	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000133347	5	145239328 - 145239329	5	145859765 - 145859766	133347	137086	rs587777424	NC_000005.10:145859765:A:AA
NM_001127453.2(GSDME):c.119dup (p.Lys41fs)	GSDME	K41fs	Nonsyndromic hearing loss and deafness|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 15, 2021)	criteria provided, conflicting interpretations	VCV000228555	7	24789274 - 24789275	7	24749655 - 24749656	228555	229599	rs758488919	NC_000007.14:24749655:TTTTTT:TTTTTTT
NM_001127453.2(GSDME):c.1193_1196dup (p.Ser399delinsArgTer)	GSDME		Deafness, autosomal dominant 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2020)	criteria provided, conflicting interpretations	VCV000225338	7	24742439 - 24742440	7	24702820 - 24702821	225338	227308	rs757421220	NC_000007.14:24702820:CTATCT:CTATCTATCT
NM_012205.3(HAAO):c.483dup (p.Asp162Ter)	HAAO	D162*	Congenital NAD deficiency disorder|Vertebral, cardiac, renal, and limb defects syndrome 1	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000403727	2	42997283 - 42997284	2	42770144	403727	390708	rs527656756	NC_000002.12:42770143:A:AA
NM_004839.4(HOMER2):c.807dup (p.Met270fs)	HOMER2	M270fs, M281fs	Deafness, autosomal dominant 68	Pathogenic(Last reviewed: Jun 18, 2020)	no assertion criteria provided	VCV000922123	15	83519938 - 83519939	15	82851186 - 82851187	922123	916783		NC_000015.10:82851186:G:GG
NM_001540.5(HSPB1):c.74_95dup (p.Phe33_Gly34insTer)	HSPB1		Charcot-Marie-Tooth disease axonal type 2F	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001062122	7	75932100 - 75932101	7	76302783 - 76302784	1062122	1045118		NC_000007.14:76302783:GCATAGCCGCCTCTTCGACCAGGC:GCATAGCCGCCTCTTCGACCAGGCATAGCCGCCTCTTCGACCAGGC
NM_001540.5(HSPB1):c.365-5dup	HSPB1		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916741	7	75933108 - 75933109	7	76303791 - 76303792	916741	905603		NC_000007.14:76303791:CCCCCC:CCCCCCC
NM_001540.5(HSPB1):c.438dup (p.Gly147fs)	HSPB1	G147fs	Charcot-Marie-Tooth disease axonal type 2F|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2020)	criteria provided, conflicting interpretations	VCV000916358	7	75933304 - 75933305	7	76303987 - 76303988	916358	904502		NC_000007.14:76303987:CCCCCC:CCCCCCC
NM_001540.5(HSPB1):c.609dup (p.Ala204fs)	HSPB1	A204fs	Charcot-Marie-Tooth disease axonal type 2F	Uncertain significance(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000846632	7	75933479 - 75933480	7	76304162 - 76304163	846632	833845		NC_000007.14:76304162:CC:CCC
NM_001540.5(HSPB1):c.233_234delinsTT (p.Ser78Ile)	HSPB1	S78I	Charcot-Marie-Tooth disease axonal type 2F	Uncertain significance(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000841120	7	75932262 - 75932263	7	76302945 - 76302946	841120	833840		NC_000007.14:76302944:GC:TT
NC_000007.14:g.(?_76301442)_(76304183_?)dup	HSPB1		Charcot-Marie-Tooth disease axonal type 2F	Uncertain significance(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000831633	7	75930759 - 75933500			831633	819916		
NM_001540.5(HSPB1):c.171_172insGCGCCCT (p.Leu58fs)	HSPB1	L58fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637505	7	75932200 - 75932201	7	76302883 - 76302884	637505	625147	rs1583964560	NC_000007.14:76302883::GCGCCCT
NM_001540.5(HSPB1):c.248_249delinsAT (p.Ser83Asn)	HSPB1	S83N	Charcot-Marie-Tooth disease axonal type 2F|not provided	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618680	7	75932277 - 75932278	7	76302960 - 76302961	618680	609669	rs1563651975	NC_000007.14:76302959:GC:AT
NC_000007.13:g.(?_75931813)_(75933510_?)dup	HSPB1		Charcot-Marie-Tooth disease axonal type 2F	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000583803	7	75931813 - 75933510	7	76302496 - 76304193	583803	566151		
NM_001540.5(HSPB1):c.165_171dup (p.Leu58fs)	HSPB1	L58fs	not provided|Charcot-Marie-Tooth disease axonal type 2F	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2020)	criteria provided, conflicting interpretations	VCV000452063	7	75932193 - 75932194	7	76302876 - 76302877	452063	444162	rs748762287	NC_000007.14:76302876:GCGCCCC:GCGCCCCGCGCCCC
NM_001540.5(HSPB1):c.180dup (p.Ala61fs)	HSPB1	A61fs	Charcot-Marie-Tooth disease axonal type 2F|Distal hereditary motor neuronopathy type 2B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000423339	7	75932203 - 75932204	7	76302886 - 76302887	423339	407258	rs1064796370	NC_000007.14:76302886:CCCCCC:CCCCCCC
NM_001540.5(HSPB1):c.522_523delinsCT (p.Gln175Ter)	HSPB1	Q175*	Charcot-Marie-Tooth disease axonal type 2F	Likely pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, single submitter	VCV000410713	7	75933394 - 75933395	7	76304077 - 76304078	410713	396422	rs1060503021	NC_000007.14:76304076:GC:CT
NM_014365.3(HSPB8):c.563dup (p.Asp189fs)	HSPB8	D189fs	Charcot-Marie-Tooth disease, type 2L	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001055783	12	119631634 - 119631635	12	119193829 - 119193830	1055783	1047683		NC_000012.12:119193829:A:AA
NC_000012.11:g.(?_119631494)_(119631673_?)dup	HSPB8		Charcot-Marie-Tooth disease, type 2L	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001007967	12	119631494 - 119631673			1007967	986483		
NM_014365.3(HSPB8):c.266dup (p.Pro90fs)	HSPB8	P90fs	Charcot-Marie-Tooth disease, type 2L|not provided	Uncertain significance(Last reviewed: Mar 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000804924	12	119617376 - 119617377	12	119179571 - 119179572	804924	793410	rs773017653	NC_000012.12:119179571:CCCCCCC:CCCCCCCC
NM_000618.5(IGF1):c.*263_*265delinsAAA	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306904	12	102796020 - 102796022	12	102402242 - 102402244	306904	315826	rs886048889	NC_000012.12:102402241:ATA:TTT
NM_000618.5(IGF1):c.*2375dup	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306886	12	102793909 - 102793910	12	102400131 - 102400132	306886	322907	rs35306040	NC_000012.12:102400131:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_000618.5(IGF1):c.*2377dup	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306883	12	102793907 - 102793908	12	102400129 - 102400130	306883	315811	rs886048881	NC_000012.12:102400129:T:TT
NM_000618.5(IGF1):c.*3365_*3366insGACA	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306875	12	102792919 - 102792920	12	102399141 - 102399142	306875	330175	rs886048880	NC_000012.12:102399141:TGT:TGTCTGT
NM_000618.5(IGF1):c.*3707dup	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306866	12	102792577 - 102792578	12	102398799 - 102398800	306866	315798	rs886048876	NC_000012.12:102398799:TTTTTTTTTT:TTTTTTTTTTT
NM_000618.5(IGF1):c.*4421_*4422insT	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306854	12	102791863 - 102791864	12	102398085 - 102398086	306854	315794	rs886048870	NC_000012.12:102398085::A
NM_000618.5(IGF1):c.*5718dup	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306838	12	102790566 - 102790567	12	102396788 - 102396789	306838	328921	rs200146786	NC_000012.12:102396788:TTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_000618.5(IGF1):c.*6490_*6493delinsCTAAAATGTAACTAATTGAATA	IGF1		Growth delay due to insulin-like growth factor type 1 deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000306829	12	102789792 - 102789795	12	102396014 - 102396017	306829	328883	rs886048856	NC_000012.12:102396013:AGTC:TATTCAATTAGTTACATTTTAG
NM_021999.5(ITM2B):c.787_796dup (p.Ser266fs)	ITM2B	S266fs	ADan amyloidosis	Pathogenic(Last reviewed: Apr 25, 2000)	no assertion criteria provided	VCV000005980	13	48835344 - 48835345	13	48261208 - 48261209	5980	21019	rs606231166	NC_000013.11:48261208:TTTAATTTGTT:TTTAATTTGTTTTAATTTGTT
NM_005548.3(KARS1):c.440_441dup (p.Arg148fs)	KARS1	R148fs, R176fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637488	16	75670392 - 75670393	16	75636494 - 75636495	637488	625315	rs1597170012	NC_000016.10:75636494:AA:AAAA
NM_153766.3(KCNJ1):c.*499_*501dup	KCNJ1		Antenatal Bartter Syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303561	11	128708518 - 128708519	11	128838623 - 128838624	303561	313240	rs113008742	NC_000011.10:128838623:TTGT:TTGTTGT
NM_002241.5(KCNJ10):c.934_935delinsTT (p.Thr312Leu)	KCNJ10	T312L	EAST syndrome	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000663852	1	160011388 - 160011389	1	160041598 - 160041599	663852	626984	rs1571265205	NC_000001.11:160041597:GT:AA
NC_000001.10:g.(?_160011163)_(160111132_?)dup	KCNJ9|IGSF8|ATP1A2|KCNJ10		Familial hemiplegic migraine|EAST syndrome	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000470189	1	160011163 - 160111132			470189	446919		
NM_000218.3(KCNQ1):c.743_744delinsTC (p.Trp248Phe)	KCNQ1	W121F, W248F	Jervell and Lange-Nielsen syndrome 1	not provided	no assertion provided	VCV000053093	11	2593302 - 2593303	11	2572072 - 2572073	53093	67761	rs397508123	NC_000011.10:2572071:GG:TC
NM_000218.3(KCNQ1):c.567dup (p.Arg190fs)	KCNQ1	R190fs, R63fs	Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 1|not provided|Long QT syndrome	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000053069	11	2591942 - 2591943	11	2570712 - 2570713	53069	67737	rs397508117	NC_000011.10:2570712:GGGGG:GGGGGG
NM_000218.3(KCNQ1):c.1630_1635delinsGTTGAGA (p.Gln544fs)	KCNQ1	Q417fs, Q544fs	Jervell and Lange-Nielsen syndrome 1	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000052999	11	2797229 - 2797234	11	2775999 - 2776004	52999	67667	rs397515637	NC_000011.10:2775998:CAGTAC:GTTGAGA
NM_000218.3(KCNQ1):c.1149dup (p.Ala384fs)	KCNQ1	A384fs, A257fs	Jervell and Lange-Nielsen syndrome 1	not provided	no assertion provided	VCV000052965	11	2608819 - 2608820	11	2587589 - 2587590	52965	67633	rs397508079	NC_000011.10:2587589:T:TT
NM_004700.4(KCNQ4):c.1667_1671dup (p.Val558fs)	KCNQ4	V558fs, V504fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000505873	1	41300691 - 41300692	1	40835019 - 40835020	505873	496627	rs1553168601	NC_000001.11:40835019:ACGAC:ACGACACGAC
NM_001365951.3(KIF1B):c.3688+7_3688+8dup	KIF1B		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000916761	1	10403350 - 10403351	1	10343292 - 10343293	916761	905540		NC_000001.11:10343292:CAC:CACAC
NM_001365951.3(KIF1B):c.4525dup (p.Arg1509fs)	KIF1B	R1509fs, R1463fs	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694940	1	10425476 - 10425477	1	10365418 - 10365419	694940	682967	rs377576958	NC_000001.11:10365418:CCC:CCCC
NM_001365951.3(KIF1B):c.608+8dup	KIF1B		Neuroblastoma|Charcot-Marie-Tooth disease|not provided|none provided|Charcot-Marie-Tooth disease, type 2|not specified	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220468	1	10327623 - 10327624	1	10267565 - 10267566	220468	221072	rs139613776	NC_000001.11:10267565:A:AA
NM_000899.5(KITLG):c.286_303delinsT (p.Leu95_Ser96insTer)	KITLG		Deafness, autosomal dominant 69	Pathogenic(Last reviewed: Nov 5, 2015)	no assertion criteria provided	VCV000218887	12	88912534 - 88912551	12	88518757 - 88518774	218887	215646	rs864309653	NC_000012.12:88518756:TATGATGGAATAATTACT:A
NM_003482.4(KMT2D):c.9602dup (p.Ser3202fs)	KMT2D	S3202fs	Kabuki syndrome 1|not provided|CHARGE association	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000424021	12	49431536 - 49431537	12	49037753 - 49037754	424021	408674	rs1555190375	NC_000012.12:49037753:A:AA
NM_015340.4(LARS2):c.1481dup (p.Leu495fs)	LARS2|LARS2-AS1	L495fs	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, single submitter	VCV001185590	3	45533244 - 45533245	3	45491752 - 45491753	1185590	1175559		NC_000003.12:45491752:CCCCCC:CCCCCCC
NM_182548.4(LHFPL5):c.89dup (p.Thr31fs)	LHFPL5	T31fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000667378	6	35773532 - 35773533	6	35805755 - 35805756	667378	654448	rs756030149	NC_000006.12:35805755:GGGG:GGGGG
NM_178138.6(LHX3):c.93_95dup (p.Ala32dup)	LHX3		Non-acquired combined pituitary hormone deficiency with spine abnormalities	Uncertain significance(Last reviewed: Oct 19, 2020)	no assertion criteria provided	VCV000984382	9	139092583 - 139092584	9	136200737 - 136200738	984382	972447		NC_000009.12:136200737:GCG:GCGGCG
NM_178138.6(LHX3):c.287_288delinsTCCT (p.Gly96fs)	LHX3	G101fs, G85fs, G96fs	Non-acquired combined pituitary hormone deficiency with spine abnormalities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000009025	9	139091690 - 139091691	9	136199844 - 136199845	9025	24064	rs137854504	NC_000009.12:136199843:GC:AGGA
NM_001136472.2(LITAF):c.-6+526_-6+527insT	LITAF		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000317795	16	11680215 - 11680216	16	11586359 - 11586360	317795	324082	rs886051655	NC_000016.10:11586359::A
NM_001136472.2(LITAF):c.-6+681dup	LITAF		Charcot-Marie-Tooth disease, type I|not provided	Likely benign(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000317790	16	11680060 - 11680061	16	11586204 - 11586205	317790	333690	rs398100090	NC_000016.10:11586204:T:TT
NM_001136472.2(LITAF):c.*582dup	LITAF		Charcot-Marie-Tooth disease, type I	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000317770	16	11642910 - 11642911	16	11549054 - 11549055	317770	324057	rs71406254	NC_000016.10:11549054:AAAAAAAAAA:AAAAAAAAAAA
NM_001136472.2(LITAF):c.*816dup	LITAF		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000317763	16	11642676 - 11642677	16	11548820 - 11548821	317763	333669	rs758850868	NC_000016.10:11548820:AAAAAAAA:AAAAAAAAA
NM_018368.4(LMBRD1):c.981-10dup	LMBRD1		Methylmalonic aciduria and homocystinuria type cblF|Disorders of Intracellular Cobalamin Metabolism|not provided|Donnai-Barrow syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)	criteria provided, conflicting interpretations	VCV000225404	6	70411439 - 70411440	6	69701547 - 69701548	225404	227302	rs202207965	NC_000006.12:69701547:AAAAAAAA:AAAAAAAAA
NM_170707.4(LMNA):c.1968+18dup	LMNA		not provided|Charcot-Marie-Tooth disease	Benign/Likely benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000917027	1	156108563 - 156108564	1	156138772 - 156138773	917027	905560		NC_000001.11:156138772:TTT:TTTT
NM_001374385.1(ATP8B1):c.2098-19_2098-15dup	LOC100505549|ATP8B1		Progressive familial intrahepatic cholestasis|not provided	Benign/Likely benign(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000327479	18	55335786 - 55335787	18	57668554 - 57668555	327479	342158	rs34422185	NC_000018.10:57668554:AAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAA
NM_001384474.1(LOXHD1):c.4794_4795insTC (p.Ile1599fs)	LOXHD1	I1599fs, I392fs, I488fs	not provided|Deafness, autosomal recessive 77	Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000817890	18	44104510 - 44104511	18	46524547 - 46524548	817890	806020	rs1598914701	NC_000018.10:46524547::GA
NM_001384474.1(LOXHD1):c.4476_4477insT (p.Glu1493Ter)	LOXHD1	E1493*, E382*, E286*	not provided|Deafness, autosomal recessive 77	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2020)	criteria provided, conflicting interpretations	VCV000632297	18	44109193 - 44109194	18	46529230 - 46529231	632297	620620	rs763478051	NC_000018.10:46529230::A
NM_001384474.1(LOXHD1):c.5115_5127dup (p.Glu1710fs)	LOXHD1	E503fs, E599fs, E1710fs	Deafness, autosomal recessive 77	Uncertain significance(Last reviewed: Oct 26, 2015)	no assertion criteria provided	VCV000417904	18	44101203 - 44101204	18	46521240 - 46521241	417904	404837	rs1555669048	NC_000018.10:46521240:CACCAGCCAGCAGC:CACCAGCCAGCAGCACCAGCCAGCAGC
NM_001384474.1(LOXHD1):c.6080dup (p.Gly2028fs)	LOXHD1	G1966fs, G821fs, G917fs, G267fs, G2028fs	Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236044	18	44065083 - 44065084	18	46485120 - 46485121	236044	237624	rs878853231	NC_000018.10:46485120:CC:CCC
NM_001384474.1(LOXHD1):c.2874_2891dup (p.Ser960_Ser965dup)	LOXHD1		not specified|Deafness, autosomal recessive 77|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2019)	criteria provided, conflicting interpretations	VCV000228821	18	44140215 - 44140216	18	46560252 - 46560253	228821	230950	rs759237437	NC_000018.10:46560252:GAGGACTCCTCTGATGAGGA:GAGGACTCCTCTGATGAGGAGGACTCCTCTGATGAGGA
NM_004525.3(LRP2):c.*908_*910dup	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332054	2	169984262 - 169984263	2	169127752 - 169127753	332054	284942	rs11411235	NC_000002.12:169127752:TTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_004525.3(LRP2):c.*909_*910dup	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332053	2	169984262 - 169984263	2	169127752 - 169127753	332053	283416	rs11411235	NC_000002.12:169127752:TTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_004525.3(LRP2):c.*910dup	LRP2		Donnai-Barrow syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332052	2	169984262 - 169984263	2	169127752 - 169127753	332052	282642	rs11411235	NC_000002.12:169127752:TTTTTTTTTTTT:TTTTTTTTTTTTT
NM_004525.3(LRP2):c.*1127_*1129dup	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332048	2	169984043 - 169984044	2	169127533 - 169127534	332048	285445	rs3083240	NC_000002.12:169127533:AAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAAA
NM_004525.3(LRP2):c.*1128_*1129dup	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332047	2	169984043 - 169984044	2	169127533 - 169127534	332047	284940	rs3083240	NC_000002.12:169127533:AAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAA
NM_004525.3(LRP2):c.*1129dup	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332046	2	169984043 - 169984044	2	169127533 - 169127534	332046	283413	rs3083240	NC_000002.12:169127533:AAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAA
NM_004525.3(LRP2):c.*1130_*1131insT	LRP2		Donnai-Barrow syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000332045	2	169984042 - 169984043	2	169127532 - 169127533	332045	283412	rs886055071	NC_000002.12:169127532::A
NM_004525.3(LRP2):c.13139dup (p.Cys4381fs)	LRP2	C4381fs	not provided|Donnai-Barrow syndrome	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000021419	2	169997024 - 169997025	2	169140514 - 169140515	21419	34271	rs80338754	NC_000002.12:169140514:GGGGGGGG:GGGGGGGGG
NM_001005373.4(LRSAM1):c.602dup (p.Leu201fs)	LRSAM1	L201fs	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001076924	9	130230090 - 130230091	9	127467811 - 127467812	1076924	1061542		NC_000009.12:127467811:TT:TTT
NM_001005373.4(LRSAM1):c.1956_1957dup (p.Gln653fs)	LRSAM1	Q390fs, Q620fs, Q626fs, Q653fs	Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001046625	9	130263327 - 130263328	9	127501048 - 127501049	1046625	1028851		NC_000009.12:127501048:CCCCCC:CCCCCCCC
NM_001005373.4(LRSAM1):c.21_41dup (p.Pro10_Lys16dup)	LRSAM1		Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000961151	9	130216826 - 130216827	9	127454547 - 127454548	961151	946343		NC_000009.12:127454547:GCGGAAACCCAGTGAGGAGGC:GCGGAAACCCAGTGAGGAGGCGCGGAAACCCAGTGAGGAGGC
NM_001005373.4(LRSAM1):c.1773_1774delinsAA (p.His592Asn)	LRSAM1	H592N, H565N, H329N, H559N	Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Aug 11, 2019)	criteria provided, single submitter	VCV000959968	9	130258317 - 130258318	9	127496038 - 127496039	959968	946346		NC_000009.12:127496037:GC:AA
NM_001005373.4(LRSAM1):c.1016dup (p.Gln340fs)	LRSAM1	Q340fs, Q77fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000917119	9	130242229 - 130242230	9	127479950 - 127479951	917119	905252		NC_000009.12:127479950:T:TT
NM_001005373.4(LRSAM1):c.1912+4_1912+5delinsTC	LRSAM1		Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000851234	9	130259617 - 130259618	9	127497338 - 127497339	851234	852475		NC_000009.12:127497337:CA:TC
NM_001005373.4(LRSAM1):c.1978_1979dup (p.Pro661fs)	LRSAM1	P634fs, P661fs, P398fs, P628fs	Charcot-Marie-Tooth disease type 2P	Likely pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000841754	9	130263352 - 130263353	9	127501073 - 127501074	841754	835455		NC_000009.12:127501073:GAG:GAGAG
NC_000009.12:g.(?_127454518)_(127502909_?)dup	LRSAM1		Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832410	9	130216797 - 130265188			832410	820047		
NM_001005373.4(LRSAM1):c.2019dup (p.Glu674fs)	LRSAM1	E647fs, E674fs, E411fs, E641fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2P	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000651567	9	130263394 - 130263395	9	127501115 - 127501116	651567	637669	rs1315010600	NC_000009.12:127501115:A:AA
NM_001005373.4(LRSAM1):c.1957dup (p.Gln653fs)	LRSAM1	Q626fs, Q653fs, Q390fs, Q620fs	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000639489	9	130263327 - 130263328	9	127501048 - 127501049	639489	637668	rs775965001	NC_000009.12:127501048:CCCCCC:CCCCCCC
NM_001005373.4(LRSAM1):c.1026_1027delinsTT (p.Leu342_Leu343=)	LRSAM1		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2P	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000540013	9	130242240 - 130242241	9	127479961 - 127479962	540013	524209	rs1554757292	NC_000009.12:127479960:GC:TT
NM_001005373.4(LRSAM1):c.2043_2044dup (p.Glu682fs)	LRSAM1	E655fs, E682fs, E419fs, E649fs	Charcot-Marie-Tooth disease type 2P	Uncertain significance(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000472798	9	130263417 - 130263418	9	127501138 - 127501139	472798	459264	rs1554762671	NC_000009.12:127501138:GGG:GGGGG
NM_001005373.4(LRSAM1):c.2121_2122dup (p.Leu708fs)	LRSAM1	L681fs, L708fs, L445fs, L675fs	Charcot-Marie-Tooth disease type 2P	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000030860	9	130265125 - 130265126	9	127502846 - 127502847	30860	39817	rs786200930	NC_000009.12:127502846:CGC:CGCGC
NM_001038603.3(MARVELD2):c.608dup (p.Leu203fs)	MARVELD2	L203fs	Deafness, autosomal recessive 49	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001299311	5	68715816 - 68715817	5	69419989 - 69419990	1299311	1289170		NC_000005.10:69419989:TTTT:TTTTT
NM_030973.4(MED25):c.1101+24_1101+42dup	MED25		Charcot-Marie-Tooth disease	Benign	criteria provided, single submitter	VCV000917143	19	50334159 - 50334160	19	49830902 - 49830903	917143	905713		NC_000019.10:49830902:CCTCCTGCCCCTGCTCCTTCCTCCTGC:CCTCCTGCCCCTGCTCCTTCCTCCTGCCCCTGCTCCTTCCTCCTGC
NM_014874.4(MFN2):c.306dup (p.Gly103fs)	MFN2	G103fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637751	1	12052735 - 12052736	1	11992678 - 11992679	637751	624896	rs777012596	NC_000001.11:11992678:TTTTTTT:TTTTTTTT
NM_014874.4(MFN2):c.2258dup (p.Gln754fs)	MFN2	Q754fs	Charcot-Marie-Tooth disease, type 2A2A|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2020)	criteria provided, conflicting interpretations	VCV000637433	1	12071605 - 12071606	1	12011548 - 12011549	637433	624971	rs773371488	NC_000001.11:12011548:T:TT
NM_014874.4(MFN2):c.2230_2231delinsAT (p.Glu744Met)	MFN2	E744M	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637305	1	12071578 - 12071579	1	12011521 - 12011522	637305	624967	rs1569890153	NC_000001.11:12011520:GA:AT
NM_014874.4(MFN2):c.30dup (p.Ile11fs)	MFN2	I11fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637294	1	12049254 - 12049255	1	11989197 - 11989198	637294	624885	rs1569802246	NC_000001.11:11989197:T:TT
NM_001354604.2(MITF):c.709dup (p.Tyr237fs)	MITF	Y185fs, Y220fs, Y221fs, Y74fs, Y130fs, Y236fs, Y237fs	Cutaneous malignant melanoma 8|Tietz syndrome|Waardenburg syndrome type 2A	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000864796	3	69990427 - 69990428	3	69941276 - 69941277	864796	828567		NC_000003.12:69941276:TT:TTT
NM_001354604.2(MITF):c.773_785dup (p.Asp263fs)	MITF	D211fs, D246fs, D247fs, D100fs, D156fs, D262fs, D263fs	Rare genetic deafness	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000505620	3	69998210 - 69998211	3	69949059 - 69949060	505620	496807	rs1553703619	NC_000003.12:69949059:TCGGGAAACTTGAT:TCGGGAAACTTGATCGGGAAACTTGAT
NM_001354604.2(MITF):c.*2159dup	MITF		Waardenburg syndrome|Tietz syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346534	3	70016551 - 70016552	3	69967400 - 69967401	346534	296060	rs550555819	NC_000003.12:69967400:GGGGGGG:GGGGGGGG
NM_001354604.2(MITF):c.*574_*576dup	MITF		Waardenburg syndrome|Tietz syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346517	3	70014965 - 70014966	3	69965814 - 69965815	346517	296048	rs59665466	NC_000003.12:69965814:AAAAAAAAAA:AAAAAAAAAAAAA
NM_001354604.2(MITF):c.*575_*576dup	MITF		Waardenburg syndrome|Tietz syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346516	3	70014965 - 70014966	3	69965814 - 69965815	346516	291455	rs59665466	NC_000003.12:69965814:AAAAAAAAAA:AAAAAAAAAAAA
NM_001354604.2(MITF):c.*576dup	MITF		Waardenburg syndrome|Tietz syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346515	3	70014965 - 70014966	3	69965814 - 69965815	346515	291457	rs59665466	NC_000003.12:69965814:AAAAAAAAAA:AAAAAAAAAAA
NM_000530.8(MPZ):c.491dup (p.Val165fs)	MPZ	V165fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV000949390	1	161276211 - 161276212	1	161306421 - 161306422	949390	921717		NC_000001.11:161306421:CCCCC:CCCCCC
NC_000001.11:g.(?_161305674)_(161309915_?)dup	MPZ		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000830394	1	161275464 - 161279705			830394	818850		
NM_000530.8(MPZ):c.645+2dup	MPZ		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637484	1	161275894 - 161275895	1	161306104 - 161306105	637484	625002	rs1571817455	NC_000001.11:161306104:AA:AAA
NM_000530.8(MPZ):c.550_552delinsG (p.Leu184fs)	MPZ	L184fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637357	1	161276151 - 161276153	1	161306361 - 161306363	637357	625012	rs1571818007	NC_000001.11:161306360:TAG:C
NM_000530.8(MPZ):c.-10_-6dup	MPZ		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637353	1	161279700 - 161279701	1	161309910 - 161309911	637353	625096	rs1571822935	NC_000001.11:161309910:GGGCAGGG:GGGCAGGGCAGGG
NM_000530.8(MPZ):c.646dup (p.Thr216fs)	MPZ	T216fs	Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000462798	1	161275766 - 161275767	1	161305976 - 161305977	462798	447420	rs1553259511	NC_000001.11:161305976:T:TT
NM_000530.8(MPZ):c.266_270dup (p.Glu91fs)	MPZ	E91fs	not provided|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000444185	1	161276675 - 161276676	1	161306885 - 161306886	444185	437825	rs1553259697	NC_000001.11:161306885:GTCAA:GTCAAGTCAA
NM_000530.8(MPZ):c.380_383dup (p.Asp128delinsGluTer)	MPZ		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, single submitter	VCV000411659	1	161276562 - 161276563	1	161306772 - 161306773	411659	390859	rs1553259651	NC_000001.11:161306772:TCAC:TCACTCAC
NM_000530.8(MPZ):c.368_369delinsCT (p.Gly123Ala)	MPZ	G123A	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000237876	1	161276577 - 161276578	1	161306787 - 161306788	237876	238156	rs878854030	NC_000001.11:161306786:GC:AG
NM_003001.3(SDHC):c.20+11_20+12dup	MPZ|SDHC		Charcot-Marie-Tooth, Intermediate|Congenital hypomyelinating neuropathy 1, autosomal recessive|Hereditary cancer-predisposing syndrome|not provided|not specified|Roussy-Lvy syndrome|Paragangliomas 3|Gastrointestinal stromal tumor|Charcot-Marie-Tooth disease, type I|Pheochromocytoma	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000044647	1	161284226 - 161284227	1	161314434 - 161314435	44647	53814	rs35215598	NC_000001.11:161314434:GTG:GTGTG
NM_005797.4(MPZL2):c.319_320dup (p.Ile108fs)	MPZL2	I108fs	Deafness, autosomal recessive 111	Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV001301681	11	118133268 - 118133269	11	118262553 - 118262554	1301681	1291964		NC_000011.10:118262553:GAG:GAGAG
m.961delTinsC(2_7)	MT-RNR1		Aminoglycoside-induced deafness	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000009629	MT	961	MT	961	9629	24668	rs1556422499	
NC_012920.1:m.7471dup	MT-TS1		Deafness, sensorineural, with neurologic features|Mitochondrial cytochrome c oxidase deficiency|Deafness, nonsyndromic sensorineural, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000042226	MT	7465 - 7466	MT	7465 - 7466	42226	51396	rs111033319	NC_012920.1:7465:CCCCCC:CCCCCCC
NM_016156.6(MTMR2):c.1736_1745delinsCC (p.Tyr579fs)	MTMR2	Y507fs, Y579fs	Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: Sep 10, 2020)	no assertion criteria provided	VCV000993001	11	95569337 - 95569346	11	95836173 - 95836182	993001	980944		NC_000011.10:95836172:CTTATGTAAT:GG
NM_016156.6(MTMR2):c.1770+7_1770+19delinsC	MTMR2		not specified|Charcot-Marie-Tooth disease	Likely benign(Last reviewed: Feb 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418333	11	95569293 - 95569305	11	95836129 - 95836141	418333	408497	rs1555056865	NC_000011.10:95836128:TATATTGTAAGGC:G
MTMR2, 10-BP DEL/2-BP INS	MTMR2		Charcot-Marie-Tooth disease, type 4B1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000006235					6235	21274		
NM_002473.6(MYH9):c.3195_3215dup (p.Gln1068_Leu1074dup)	MYH9		Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014085	22	36692945 - 36692946	22	36296899 - 36296900	14085	29124	rs876661302	NC_000022.11:36296899:GCGATCTGGGCCTGGAGCTCGGCGATCTGG:GCGATCTGGGCCTGGAGCTCGGCGATCTGGGCCTGGAGCTCGGCGATCTGG
NM_016239.4(MYO15A):c.8897_8900dup (p.Ala2968fs)	MYO15A	A2968fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000984792	17	18061141 - 18061142	17	18157827 - 18157828	984792	972890		NC_000017.11:18157827:CGGCCG:CGGCCGGCCG
NM_016239.4(MYO15A):c.4571dup (p.Lys1525fs)	MYO15A	K1525fs	Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000984791	17	18039112 - 18039113	17	18135798 - 18135799	984791	972889		NC_000017.11:18135798:A:AA
NM_016239.4(MYO15A):c.7745_8224+177delinsCTCCCCGGAACGGCTGCTGGTAC	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000813827	17	18054799 - 18058246	17	18151485 - 18154932	813827	802078		
NM_016239.4(MYO15A):c.3524dup (p.Ser1176fs)	MYO15A	S1176fs	Deafness, autosomal recessive 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000803332	17	18025637 - 18025638	17	18122323 - 18122324	803332	791685	rs766187994	NC_000017.11:18122323:A:AA
NM_016239.4(MYO15A):c.2384dup (p.Ser796fs)	MYO15A	S796fs	Deafness, autosomal recessive 3	Uncertain significance(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000632270	17	18024493 - 18024494	17	18121179 - 18121180	632270	620573	rs1567624190	NC_000017.11:18121179:CCCCC:CCCCCC
NM_016239.4(MYO15A):c.8005dup (p.Thr2669fs)	MYO15A	T2669fs	Deafness, autosomal recessive 3|not provided	Likely pathogenic(Last reviewed: Jan 5, 2021)	criteria provided, single submitter	VCV000504407	17	18057126 - 18057127	17	18153812 - 18153813	504407	495663	rs1221876133	NC_000017.11:18153812:A:AA
NC_000017.1:g.18054799_18058246delinsCTCCCCGGAACGGCTGCTGGTAC	MYO15A		Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236039					236039	237627		
NM_016239.4(MYO15A):c.1185dup (p.Glu396fs)	MYO15A	E396fs	Rare genetic deafness|Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228372	17	18023292 - 18023293	17	18119978 - 18119979	228372	230688	rs772536599	NC_000017.11:18119978:CCCCCCC:CCCCCCCC
NM_016239.4(MYO15A):c.3311dup (p.Gly1104_Glu1105insTer)	MYO15A		not provided|Deafness, autosomal recessive 3	Pathogenic(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000203363	17	18025419 - 18025420	17	18122105 - 18122106	203363	199805	rs794729637	NC_000017.11:18122105:GGGGGG:GGGGGGG
NM_016239.4(MYO15A):c.7006dup (p.Gln2336fs)	MYO15A	Q2336fs	Rare genetic deafness	Pathogenic(Last reviewed: Jan 8, 2013)	criteria provided, single submitter	VCV000045757	17	18052575 - 18052576	17	18149261 - 18149262	45757	54922	rs397517286	NC_000017.11:18149261:CCCC:CCCCC
NM_005379.4(MYO1A):c.347_349dup (p.Ser116dup)	MYO1A		Deafness, autosomal dominant 48	Uncertain significance(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000008147	12	57441167 - 57441168	12	57047383 - 57047384	8147	23186	rs864309476	NC_000012.12:57047383:AAGA:AAGAAGA
NM_017433.5(MYO3A):c.1588dup (p.Tyr530fs)	MYO3A	Y530fs	Deafness, autosomal recessive 30	Uncertain significance(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000631633	10	26385329 - 26385330	10	26096400 - 26096401	631633	620356	rs1564543838	NC_000010.11:26096400:TTTTTT:TTTTTTT
NM_004999.4(MYO6):c.1452dup (p.Asn485Ter)	MYO6	N480*, N485*	Autosomal dominant nonsyndromic deafness 22	Pathogenic(Last reviewed: Jul 6, 2019)	no assertion criteria provided	VCV000917516	6	76568683 - 76568684	6	75858966 - 75858967	917516	905843		NC_000006.12:75858966:TTTTTT:TTTTTTT
NM_004999.4(MYO6):c.258_259delinsCTTTACTAAA (p.Tyr87fs)	MYO6	Y87fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000667412	6	76538327 - 76538328	6	75828610 - 75828611	667412	654466	rs1583208411	NC_000006.12:75828609:TT:CTTTACTAAA
NM_004999.4(MYO6):c.1473_1473+2delinsC	MYO6		Autosomal dominant nonsyndromic deafness 22	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236034	6	76568710 - 76568712	6	75858993 - 75858995	236034	237602	rs878853225	NC_000006.12:75858992:GGT:C
NM_004999.4(MYO6):c.3207_3212delinsATCCTACATACTTAAAATTTCTT (p.Ala1070fs)	MYO6	A1079fs, A1066fs, A1070fs, A1047fs, A1042fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	VCV000179643	6	76617352 - 76617357	6	75907635 - 75907640	179643	174151	rs727505015	NC_000006.12:75907634:TGCTGG:ATCCTACATACTTAAAATTTCTT
NM_004999.4(MYO6):c.2111dup (p.Tyr705fs)	MYO6	Y700fs, Y705fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000045141	6	76589568 - 76589569	6	75879851 - 75879852	45141	54308	rs397517045	NC_000006.12:75879851:GG:GGG
NM_004999.4(MYO6):c.36dup (p.Thr13fs)	MYO6	T13fs	Deafness, autosomal recessive 37	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000008578	6	76527299 - 76527300	6	75817582 - 75817583	8578	23617	rs1562201376	NC_000006.12:75817582:T:TT
NM_000260.4(MYO7A):c.1798-7_1800delinsATCGGCTGCT	MYO7A		not provided|Usher syndrome type 1|Usher syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000929939	11	76883787 - 76883796	11	77172741 - 77172750	929939	918364		NC_000011.10:77172740:CCCCCAGGGC:ATCGGCTGCT
NM_000260.4(MYO7A):c.224dup (p.Asp75fs)	MYO7A	D64fs, D75fs	not provided|Deafness, autosomal recessive 2|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553215	11	76858934 - 76858935	11	77147888 - 77147889	553215	546612	rs1224819887	NC_000011.10:77147888:A:AA
NM_000260.4(MYO7A):c.1623dup (p.Lys542fs)	MYO7A	K542fs, K531fs	Usher syndrome type 1|not provided|Inborn genetic diseases|Retinal dystrophy|Usher syndrome type 1B	Pathogenic(Last reviewed: Apr 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000521129	11	76873960 - 76873961	11	77162914 - 77162915	521129	511946	rs782077721	NC_000011.10:77162914:CCCCCCC:CCCCCCCC
NM_000260.4(MYO7A):c.6231dup (p.Lys2078fs)	MYO7A	K2040fs, K2029fs, K2078fs	Rare genetic deafness	Pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	VCV000179745	11	76922374 - 76922375	11	77211329 - 77211330	179745	175237	rs730880367	NC_000011.10:77211329:GG:GGG
NM_000260.4(MYO7A):c.3564_3571delinsA (p.Tyr1188_Gly1191delinsTer)	MYO7A		Rare genetic deafness	Pathogenic(Last reviewed: May 13, 2013)	criteria provided, single submitter	VCV000179061	11	76900449 - 76900456	11	77189404 - 77189411	179061	178260	rs797044513	NC_000011.10:77189403:TGCCCGGG:A
NM_000260.4(MYO7A):c.5581dup (p.Arg1861fs)	MYO7A	R1812fs, R1823fs, R1861fs	Rare genetic deafness	Pathogenic(Last reviewed: Mar 11, 2010)	criteria provided, single submitter	VCV000043289	11	76916604 - 76916605	11	77205559 - 77205560	43289	52459	rs397516320	NC_000011.10:77205559:CCC:CCCC
NM_000260.4(MYO7A):c.5208dup (p.Lys1737fs)	MYO7A	K1737fs, K1688fs, K1699fs	Retinal dystrophy|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043275	11	76914142 - 76914143	11	77203097 - 77203098	43275	52445	rs111033276	NC_000011.10:77203097:CC:CCC
NM_000260.4(MYO7A):c.4544_4551delinsCA (p.Glu1515_Met1517delinsAla)	MYO7A		Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043245	11	76909642 - 76909649	11	77198597 - 77198604	43245	52415	rs111033259	NC_000011.10:77198596:AGATCATG:CA
NM_000260.4(MYO7A):c.397dup (p.His133fs)	MYO7A	H122fs, H133fs	Deafness, autosomal recessive 2|not provided|Deafness, autosomal recessive|Rare genetic deafness|Usher syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043229	11	76867057 - 76867058	11	77156011 - 77156012	43229	52399	rs111033187	NC_000011.10:77156011:CCCCCCC:CCCCCCCC
NM_000260.4(MYO7A):c.3728dup (p.Pro1244fs)	MYO7A	P1233fs, P1244fs	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Jan 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043219	11	76901160 - 76901161	11	77190115 - 77190116	43219	52389	rs397516304	NC_000011.10:77190115:CC:CCC
NM_000260.4(MYO7A):c.1952_1953insAG (p.Cys652fs)	MYO7A	C641fs, C652fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Dec 13, 2009)	criteria provided, single submitter	VCV000043165	11	76885818 - 76885819	11	77174772 - 77174773	43165	52335	rs111033510	NC_000011.10:77174772::AG
NM_000260.4(MYO7A):c.1833_1838dup (p.Gln613_Phe614insHisSer)	MYO7A		Rare genetic deafness	Likely pathogenic(Last reviewed: May 14, 2012)	criteria provided, single submitter	VCV000043159	11	76883828 - 76883829	11	77172782 - 77172783	43159	52329	rs397516290	NC_000011.10:77172782:CAGCCA:CAGCCACAGCCA
NM_000260.4(MYO7A):c.1401_1403dup (p.His468_Val469insGln)	MYO7A		not specified|not provided|Usher syndrome type 1|Deafness, autosomal recessive 2	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043145	11	76873222 - 76873223	11	77162176 - 77162177	43145	52315	rs111033219	NC_000011.10:77162176:GCA:GCAGCA
MYO7A, 1-BP INS, EX28	MYO7A		Deafness, autosomal recessive 2	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000011855					11855	26894		
NM_006096.4(NDRG1):c.756-5_756-4delinsTG	NDRG1		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000917156	8	134260173 - 134260174	8	133247930 - 133247931	917156	905606		NC_000008.11:133247929:GG:CA
NM_006096.4(NDRG1):c.681dup (p.Ile228fs)	NDRG1	I162fs, I228fs, I147fs, I245fs	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, multiple submitters, no conflicts	VCV000246500	8	134262699 - 134262700	8	133250456 - 133250457	246500	244510	rs879254290	NC_000008.11:133250456:G:GG
NM_006158.5(NEFL):c.993_994insT (p.Gln332fs)	NEFL	Q332fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000916805	8	24813036 - 24813037	8	24955522 - 24955523	916805	905227		NC_000008.11:24955522::A
NM_006158.5(NEFL):c.999_1004delinsTGTCG (p.Gln334fs)	NEFL	Q334fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000916804	8	24813026 - 24813031	8	24955512 - 24955517	916804	905226		NC_000008.11:24955511:TCCTGC:CGACA
NM_006158.5(NEFL):c.1532_1537dup (p.Gly511_Gly512dup)	NEFL		Charcot-Marie-Tooth disease type 2E	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000855560	8	24810417 - 24810418	8	24952904 - 24952905	855560	834551		NC_000008.11:24952904:CACCTCC:CACCTCCACCTCC
NM_006158.5(NEFL):c.1438_1440delinsAGA (p.Glu480Arg)	NEFL	E480R	Charcot-Marie-Tooth disease type 2E	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000663136	8	24811038 - 24811040	8	24953525 - 24953527	663136	637025	rs1586126391	NC_000008.11:24953524:CTC:TCT
NC_000008.10:g.(?_24810303)_(24814049_?)dup	NEFL		Charcot-Marie-Tooth disease type 2E	Uncertain significance(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000652961	8	24810303 - 24814049			652961	651836		
NM_006158.5(NEFL):c.990_1013dup (p.Glu330_Glu337dup)	NEFL		Charcot-Marie-Tooth disease type 2E	Uncertain significance(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000651363	8	24813016 - 24813017	8	24955502 - 24955503	651363	637033	rs1586127947	NC_000008.11:24955502:TCCTCCAGCTCCTGCAGCTGCTTCTCC:TCCTCCAGCTCCTGCAGCTGCTTCTCCTCCAGCTCCTGCAGCTGCTTCTCC
NC_000008.10:g.(?_24810313)_(24814039_?)dup	NEFL		Charcot-Marie-Tooth disease type 2E	Uncertain significance(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000647457	8	24810313 - 24814039			647457	651712		
NM_006158.5(NEFL):c.338_339delinsCC (p.Gln113Pro)	NEFL	Q113P	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2E|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000464926	8	24813691 - 24813692	8	24956177 - 24956178	464926	458664	rs1554497641	NC_000008.11:24956176:CT:GG
NM_006158.4(NEFL):c.78_81delinsTTCT (p.Ile26_Ser27=)	NEFL		Charcot-Marie-Tooth disease type 2E	Likely benign(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000417205	8	24813949 - 24813952	8	24956435 - 24956438	417205	396778	rs1060504999	NC_000008.11:24956434:GGAG:AGAA
NM_006158.5(NEFL):c.48_60dup (p.Thr21fs)	NEFL	T21fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2E|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000066694	8	24813969 - 24813970	8	24956455 - 24956456	66694	77591	rs58640772	NC_000008.11:24956455:CTCCACGTAGCGCC:CTCCACGTAGCGCCTCCACGTAGCGCC
NM_006158.5(NEFL):c.22_23delinsAG (p.Pro8Arg)	NEFL	P8R	Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease type 2E|not provided	Pathogenic(Last reviewed: Dec 15, 2007)	no assertion criteria provided	VCV000014030	8	24814007 - 24814008	8	24956493 - 24956494	14030	29069	rs60261494	NC_000008.11:24956492:GG:CT
NM_004895.4(NLRP3):c.*351dup	NLRP3		Chronic infantile neurological, cutaneous and articular syndrome|Familial cold autoinflammatory syndrome|Familial amyloid nephropathy with urticaria AND deafness	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000296959	1	247612151 - 247612152	1	247448849 - 247448850	296959	282018	rs397821684	NC_000001.11:247448849:TTTTTT:TTTTTTT
NM_001243133.2(NLRP3):c.-482dup	NLRP3		Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000296930	1	247581609 - 247581610	1	247418307 - 247418308	296930	281855	rs144128307	NC_000001.11:247418307:TTTTTTTTTTTT:TTTTTTTTTTTTT
NM_002529.4(NTRK1):c.722dup (p.Gly242fs)	NTRK1	G212fs, G242fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637894	1	156841418 - 156841419	1	156871626 - 156871627	637894	624975	rs1571693477	NC_000001.11:156871626:C:CC
NM_002529.4(NTRK1):c.1895_1896insA (p.Ser632fs)	NTRK1	S596fs, S626fs, S632fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637438	1	156849003 - 156849004	1	156879211 - 156879212	637438	624985	rs1571702751	NC_000001.11:156879211::A
NM_002529.4(NTRK1):c.1551_1552insACATCGGG (p.Glu518fs)	NTRK1	E512fs, E518fs, E482fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637436	1	156845918 - 156845919	1	156876126 - 156876127	637436	624978	rs1571699222	NC_000001.11:156876126:GGG:GGGACATCGGG
NM_002529.4(NTRK1):c.2328dup (p.Val777fs)	NTRK1	V741fs, V777fs, V771fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637431	1	156851370 - 156851371	1	156881578 - 156881579	637431	624992	rs1570912482	NC_000001.11:156881578:T:TT
NM_025136.4(OPA3):c.143-2_143-1delinsCC	OPA3		Optic atrophy 3|3-Methylglutaconic aciduria type 3	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000952107	19	46057170 - 46057171	19	45553912 - 45553913	952107	941234		NC_000019.10:45553911:CT:GG
NM_001017989.3(OPA3):c.464_467dup (p.Gln157fs)	OPA3	Q157fs	3-Methylglutaconic aciduria type 3|Optic atrophy 3	Uncertain significance(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000659433	19	46032389 - 46032390	19	45529131 - 45529132	659433	648177	rs1599947052	NC_000019.10:45529131:AGCT:AGCTAGCT
NM_025136.4(OPA3):c.305_322dup (p.Gln108_Arg109insArgArgHisGlnAlaGln)	OPA3		3-Methylglutaconic aciduria type 3|Optic atrophy 3	Uncertain significance(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000656181	19	46056989 - 46056990	19	45553731 - 45553732	656181	648178	rs1599964564	NC_000019.10:45553731:GCTGCGCCTGGTGGCGCC:GCTGCGCCTGGTGGCGCCGCTGCGCCTGGTGGCGCC
NM_025136.4(OPA3):c.142+2_142+3dup	OPA3		3-Methylglutaconic aciduria type 3|Optic atrophy 3	Uncertain significance(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000531189	19	46087877 - 46087878	19	45584619 - 45584620	531189	533159	rs1555736791	NC_000019.10:45584619:CAC:CACAC
NM_144672.4(OTOA):c.746_751delinsA (p.Ser249fs)	OTOA	S249fs, S170fs	not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228383	16	21709102 - 21709107	16	21697781 - 21697786	228383	230618	rs876657716	NC_000016.10:21697780:CTGCTT:A
NM_194248.3(OTOF):c.4467dup (p.Ile1490fs)	OTOF	I723fs, I1490fs, I800fs	Deafness, autosomal recessive 9	association(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208019	2	26689614 - 26689615	2	26466746 - 26466747	208019	204282	rs797044816	NC_000002.12:26466746:GGGG:GGGGG
NM_194248.3(OTOF):c.5800dup (p.Leu1934fs)	OTOF	L1934fs, L1244fs, L1167fs	Bilateral sensorineural hearing impairment|Deafness, autosomal recessive 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065812	2	26683527 - 26683528	2	26460659 - 26460660	65812	76720	rs397515609	NC_000002.12:26460659:GGGGG:GGGGGG
NM_194248.3(OTOF):c.2905_2923delinsCTCCGAGCGCA (p.Ala969fs)	OTOF	A222fs, A279fs, A969fs	Deafness, autosomal recessive 9|Bilateral sensorineural hearing impairment	Likely pathogenic	criteria provided, single submitter	VCV000065794	2	26698850 - 26698868	2	26475982 - 26476000	65794	76702	rs397515596	NC_000002.12:26475981:CGGCAAAGAGGCTGCGGGC:TGCGCTCGGAG
NM_194248.3(OTOF):c.2370_2371insA (p.Asp791fs)	OTOF	D791fs, D101fs, D44fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Mar 1, 2008)	criteria provided, single submitter	VCV000048193	2	26700319 - 26700320	2	26477451 - 26477452	48193	57357	rs111033370	NC_000002.12:26477451::T
NM_001292063.2(OTOG):c.5926dup (p.Gln1976fs)	OTOG	Q1988fs, Q1976fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000666980	11	17632767 - 17632768	11	17611220 - 17611221	666980	654668	rs34547529	NC_000011.10:17611220:CCCCCC:CCCCCCC
NM_001292063.2(OTOG):c.7353dup (p.Ala2452fs)	OTOG	A2464fs, A2452fs	not provided|Rare genetic deafness	Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000505170	11	17655699 - 17655700	11	17634152 - 17634153	505170	497200	rs1157646266	NC_000011.10:17634152:AA:AAA
NM_001292063.2(OTOG):c.7481-5_7482dup	OTOG		not provided|not specified|Deafness, autosomal recessive 18b	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2021)	criteria provided, conflicting interpretations	VCV000229104	11	17656384 - 17656385	11	17634837 - 17634838	229104	230152	rs1295062471	NC_000011.10:17634837:GGCCAGTG:GGCCAGTGGCCAGTG
NM_001292063.2(OTOG):c.2453_2454insACTGGACACCCA (p.Tyr818Ter)	OTOG	Y818*, Y830*	not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000228283	11	17596425 - 17596426	11	17574878 - 17574879	228283	230079	rs876657656	NC_000011.10:17574878:A:AACTGGACACCCA
NM_001378609.3(OTOGL):c.3081dup (p.Leu1028fs)	OTOGL	L1028fs, L983fs	Rare genetic deafness	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000505260	12	80696424 - 80696425	12	80302644 - 80302645	505260	497430	rs764178233	NC_000012.12:80302644:TTTTTTT:TTTTTTTT
NM_181458.4(PAX3):c.873dup (p.Gly292fs)	PAX3	G292fs, G291fs	Rare genetic deafness	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000517263	2	223086025 - 223086026	2	222221306 - 222221307	517263	496266	rs1553572976	NC_000002.12:222221306:GGG:GGGG
NM_181458.4(PAX3):c.879dup (p.Phe294fs)	PAX3	F294fs, F293fs	Rare genetic deafness|Waardenburg syndrome|Waardenburg syndrome type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000505425	2	223086019 - 223086020	2	222221300 - 222221301	505425	496265	rs1553572967	NC_000002.12:222221300:CCCCCC:CCCCCCC
NM_181458.4(PAX3):c.1420+112dup	PAX3		Craniofacial-deafness-hand syndrome|Waardenburg syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2019)	criteria provided, conflicting interpretations	VCV000334553	2	223066536 - 223066537	2	222201817 - 222201818	334553	287842	rs368725878	NC_000002.12:222201817:AAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAA
NM_001384140.1(PCDH15):c.4368-3034_4368-3027dup	PCDH15	E1468fs, E1471fs, E1488fs, E1491fs, E1498fs, E1422fs, E1451fs, E1469fs, E1493fs	not provided|Usher syndrome|Nonsyndromic Deafness	Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000432938	10	55583016 - 55583017	10	53823256 - 53823257	432938	425880	rs774056663	NC_000010.11:53823256:ATAGTATT:ATAGTATTATAGTATT
NM_001384140.1(PCDH15):c.2419dup (p.Ile807fs)	PCDH15	I814fs, I770fs, I807fs, I736fs, I785fs, I812fs, I819fs	Rare genetic deafness|Usher syndrome type 1F	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371039	10	55782758 - 55782759	10	54022998 - 54022999	371039	357859	rs781148814	NC_000010.11:54022998:T:TT
NM_001384140.1(PCDH15):c.3441dup (p.Phe1148fs)	PCDH15	F1160fs, F1077fs, F1111fs, F1126fs, F1148fs, F1153fs, F1155fs	Rare genetic deafness|Usher syndrome type 1F	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370113	10	55663062 - 55663063	10	53903302 - 53903303	370113	357850	rs770832663	NC_000010.11:53903302:TTTTTT:TTTTTTT
NM_001384140.1(PCDH15):c.4368-1501dup	PCDH15		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300163	10	55581490 - 55581491	10	53821730 - 53821731	300163	322395	rs548021914	NC_000010.11:53821730:AAAAAAAA:AAAAAAAAA
NM_001384140.1(PCDH15):c.4368-1481_4368-1478dup	PCDH15		Retinitis pigmentosa-deafness syndrome|Nonsyndromic Hearing Loss, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300161	10	55581467 - 55581468	10	53821707 - 53821708	300161	321656	rs886047057	NC_000010.11:53821707:TATCT:TATCTATCT
NC_000005.9:g.(?_136633338)_(140998481_?)dup	PCDHGA10|PCDHB6|BRD8|PCDHB@|PURA|PCDHA13|SNHG4|VTRNA1-1|PCDHGC3|PCDHB15|PCDHB9|PCDHB16|PCDHB7|HARS2|CDC23|FAM53C|DND1|SPOCK1|PCDHA10|PCDHB10|CTNNA1|PCDHGA12|GFRA3|MATR3|PCDHA7|IGIP|HNRNPA0|FAM13B|SLC35A4|PCDHA5|PCDHGB2|PCDHA6|VTRNA1-2|MYOT|PCDHB11|PCDHGB7|PCDHGA1|NME5|SIL1|PCDHB14|IK|PCDHGC5|REEP2|PCDHAC2|PCDHGA9|HSPA9|PCDHGA3|TAF7|WDR55|KIF20A|NRG2|CYSTM1|PCDHGA8|PFDN1|PAIP2|PCDHB2|APBB3|PCDHA@|ECSCR|PCDHGA7|PCDHA1|MZB1|PCDHB5|PCDHA11|PCDHGB4|CDC25C|CD14|PCDHGA11|PCDHGB5|ZMAT2|HARS1|PCDHAC1|ANKHD1-EIF4EBP3|EGR1|PCDHB12|PCDHGA2|PCDHB4|PCDHGB1|PCDHGA6|WNT8A|PCDHGB3|SLC23A1|PCDHA3|PCDHGB6|DIAPH1|PCDHA8|CXXC5|SPATA24|VTRNA1-3|PCDHA9|PCDHGA4|KDM3B|ETF1|LRRTM2|SLC4A9|PCDHB3|PCDHB8|UBE2D2|SLC25A2|PCDHA12|PROB1|PCDHGC4|KLHL3|PCDHA2|DNAJC18|TMCO6|PCDHA4|NDUFA2|ANKHD1|PCDHB1|PCDHGA5|PKD2L2|STING1|EIF4EBP3|SRA1|PSD2|HBEGF|PCDHB13		Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome|Mental retardation, autosomal dominant 31	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001020265	5	136633338 - 140998481			1020265	1001486		
NM_005391.5(PDK3):c.249-9dup	PDK3		not provided|Charcot-Marie-Tooth disease	Benign/Likely benign(Last reviewed: Jun 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000917163	X	24516925 - 24516926	X	24498808 - 24498809	917163	905726		NC_000023.11:24498808:TTTTTTTTTTTT:TTTTTTTTTTTTT
NM_005391.5(PDK3):c.1115_1116delinsAG (p.Phe372Ter)	PDK3	F372*	Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000917161	X	24552083 - 24552084	X	24533966 - 24533967	917161	905518		NC_000023.11:24533965:TT:AG
NM_001195263.2(PDZD7):c.166dup (p.Arg56fs)	PDZD7	R56fs	not provided|Deafness, autosomal recessive 57|Usher syndrome, type 2A	Pathogenic(Last reviewed: Oct 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030983	10	102789810 - 102789811	10	101030053 - 101030054	30983	39940	rs587776894	NC_000010.11:101030053:GGGGGGG:GGGGGGGG
NM_000288.4(PEX7):c.803+14dup	PEX7		Peroxisome biogenesis disorder 9B	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV001082527	6	137193400 - 137193401	6	136872262 - 136872263	1082527	1073328		NC_000006.12:136872262:TTTTT:TTTTTT
NC_000006.11:g.(?_137187765)_(137191141_?)dup	PEX7		Peroxisome biogenesis disorder 9B	Likely pathogenic(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001067455	6	137187765 - 137191141			1067455	1054391		
NM_000288.4(PEX7):c.49_70dup (p.Phe24fs)	PEX7	F24fs	Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000846733	6	137143851 - 137143852	6	136822713 - 136822714	846733	831608		NC_000006.12:136822713:CGCCACGGCTACGCCGCCGAGT:CGCCACGGCTACGCCGCCGAGTCGCCACGGCTACGCCGCCGAGT
NC_000006.12:g.(?_136821564)_(136914934_?)dup	PEX7		Peroxisome biogenesis disorder 9B	Uncertain significance(Last reviewed: Nov 17, 2019)	criteria provided, single submitter	VCV000832117	6	137142702 - 137236072			832117	819666		
NM_000288.4(PEX7):c.*257_*258insAGT	PEX7		not provided|Rhizomelic chondrodysplasia punctata|Phytanic acid storage disease	Benign(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000355539	6	137234919 - 137234920	6	136913781 - 136913782	355539	301593	rs1801001	NC_000006.12:136913781:GT:GTAGT
NM_000288.4(PEX7):c.748-5dup	PEX7		Peroxisome biogenesis disorder 9B|not specified	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198710	6	137193331	6	136872182 - 136872183	198710	195871	rs563675060	NC_000006.12:136872182:TTTTTTTTTTT:TTTTTTTTTTTT
NM_000288.4(PEX7):c.45_52dup (p.His18fs)	PEX7	H18fs	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000007784	6	137143840 - 137143841	6	136822702 - 136822703	7784	22823	rs63535662	NC_000006.12:136822702:GGACGCCGGGACGCC:GGACGCCGGGACGCCGGGACGCC
NM_001042702.5(PJVK):c.113dup (p.Lys41fs)	PJVK	K44fs, K41fs, K76fs	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000001299	2	179318248 - 179318249	2	178453521 - 178453522	1299	16338	rs1559365985	NC_000002.12:178453521:T:TT
NC_000017.10:g.(?_15134234)_(15164044_?)dup	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 4, 2020)	criteria provided, single submitter	VCV001070721	17	15134234 - 15164044			1070721	1057857		
NC_000017.10:g.(?_15134214)_(15164064_?)dup	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001070720	17	15134214 - 15164064			1070720	1057855		
NC_000017.10:g.(?_15132094)_(15169674_?)dup	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001070719	17	15132094 - 15169674			1070719	1057853		
NM_000304.4(PMP22):c.52_56delinsGCGATCGTG (p.Leu18fs)	PMP22	L18fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000969243	17	15163989 - 15163993	17	15260672 - 15260676	969243	957987		NC_000017.11:15260671:AGCAG:CACGATCGC
NC_000017.10:g.(?_15133096)_(15165152_?)dup	PMP22|MIR4731		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000660675	17	15133096 - 15165152	17	15229779 - 15261835	660675	653330		
NC_000017.10:g.(?_15142778)_(15164054_?)dup	PMP22|MIR4731		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000655765	17	15142778 - 15164054	17	15239461 - 15260737	655765	652789		
NC_000017.10:g.(?_15134228)_(15164050_?)dup	PMP22|MIR4731		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000652966	17	15134228 - 15164050	17	15230911 - 15260733	652966	652616		
NM_000304.4(PMP22):c.346_347insCC (p.Ile116fs)	PMP22	I116fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637841	17	15134370 - 15134371	17	15231053 - 15231054	637841	625374	rs1597597781	NC_000017.11:15231053::GG
NM_000304.4(PMP22):c.138_139delinsA (p.Ser47fs)	PMP22	S47fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637828	17	15162450 - 15162451	17	15259133 - 15259134	637828	625399	rs1597632913	NC_000017.11:15259132:AG:T
NC_000017.10:g.(?_15162411)_(15406546_?)dup	PMP22|TEKT3|TVP23C|CDRT4|TVP23C-CDRT4		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000583977	17	15162411 - 15406546			583977	570742		
NC_000017.10:g.(?_14139889)_(15406546_?)dup	PMP22|HS3ST3B1|TEKT3|CDRT15|TVP23C|CDRT4|TVP23C-CDRT4		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000583564	17	14139889 - 15406546			583564	574244		
NC_000017.10:g.(?_15142768)_(15142948_?)dup	PMP22		Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000531715	17	15142768 - 15142948	17	15239451 - 15239631	531715	530625		
NC_000017.10:g.(?_15134214)_(15162530_?)dup	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000462775	17	15134214 - 15162530			462775	467061		
NM_000304.3(PMP22):c.-34-?_*1140dup1657	PMP22|MIR4731		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000237630	17	15133094 - 15164078	17	15229777 - 15260761	237630	242576		
NM_000304.4(PMP22):c.280_281delinsT (p.Gly94fs)	PMP22	G94fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000220861	17	15142826 - 15142827	17	15239509 - 15239510	220861	222558	rs864622678	NC_000017.11:15239508:CC:A
NM_000304.2(PMP22):c.(?_-1)_(*1_?)dup	PMP22		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218289					218289	214924		
NM_000304.4(PMP22):c.281dup (p.Arg95fs)	PMP22	R95fs	Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2E	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008437	17	15142825 - 15142826	17	15239508 - 15239509	8437	23476	rs80338763	NC_000017.11:15239508:CCCCCC:CCCCCCC
NM_006941.4(SOX10):c.12_13delinsAT (p.Gln5Ter)	POLR2F|SOX10	Q5*	Waardenburg syndrome type 2E	Pathogenic	criteria provided, single submitter	VCV001220524	22	38379779 - 38379780	22	37983772 - 37983773	1220524	1210500		NC_000022.11:37983771:GC:AT
NM_006941.4(SOX10):c.1352_1359dup (p.His454fs)	POLR2F|SOX10	H454fs	Waardenburg syndrome type 2E|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000805532	22	38369543 - 38369544	22	37973536 - 37973537	805532	793863	rs1601878540	NC_000022.11:37973536:TGTGGGGCTGTGGG:TGTGGGGCTGTGGGGCTGTGGG
NM_006941.4(SOX10):c.698-740_1085delinsCCT	POLR2F|SOX10		Waardenburg syndrome type 4C	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000007404	22	38369818 - 38370945	22	37973811 - 37974938	7404	22443		
NM_006941.4(SOX10):c.482_483insGCTCCT (p.Met162_Gln163insLeuLeu)	POLR2F|SOX10		Waardenburg syndrome type 4C	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000007395	22	38374088 - 38374089	22	37978081 - 37978082	7395	22434	rs397515366	NC_000022.11:37978081::AGGAGC
NM_000307.5(POU3F4):c.950dup (p.Leu317fs)	POU3F4	L317fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041457	X	82764280 - 82764281	X	83509272 - 83509273	41457	49893	rs398122516	NC_000023.11:83509272:TT:TTT
NC_000001.10:g.(?_33241563)_(46663513_?)dup	PRDX1|POU3F1|GJB5|MAST2|NCDN|HMGB4|RNF19B|C1orf109|CDCA8|CITED4|AGO3|MANEAL|CLDN19|CFAP57|SLFNL1|YBX1|ELOVL1|MRPS15|IPP|MPL|ZFP69|DYNLT4|PPIE|PPIH|TOE1|ERMAP|CSMD2|TRAPPC3|TEKT2|MAP7D1|DMAP1|GNL2|FNDC5|TMEM125|AKR1A1|TESK2|C1orf122|OSCP1|GRIK3|GUCA2A|GUCA2B|EIF2B3|ARTN|MTF1|MUTYH|THRAP3|TSPAN1|CCDC30|MED8|SMIM12|AZIN2|TMEM54|HPCA|INPP5B|ZNF362|ZNF691|UTP11|RNF220|EVA1B|KIF2C|FOXJ3|FOXO6|TMEM35B|TMCO2|ZNF684|MYCL|TRIM62|POMGNT1|AGO4|CCDC24|BTBD19|CCDC17|BMP8A|SVBP|MIR30C1|FAM183A|KIAA0754|COL8A2|TMEM69|YRDC|PPCS|C1orf210|SH3D21|SNIP1|AK2|ATP6V0B|BMP8B|CDC20|PLK3|COL9A2|CSF3R|CTPS1|DPH2|EDN2|PHC2|SLC2A1|SLC6A9|TIE1|UROD|ZSCAN20|DNALI1|KCNQ4|ZMYM4|ZMYM6|IPO13|KDM4A|RIMS3|HIVEP3|GPBP1L1|CLSPN|OXCT2|RRAGC|P3H1|ZMYND12|NT5C1A|HPDL|MFSD2A|LSM10|C1orf94|CAP1|SF3A3|EBNA1BP2|ZMPSTE24|NFYC|AKIRIN1|HECTD3|ZMYM1|KIAA0319L|ZC3H12A|SCMH1|GJB4|C1orf50|TMEM53|FHL3|GJA4|ZSWIM5|GJB3|HPCAL4|MEAF6|EXO5|ARMH1|GJA9|HYI|STK40|ZFP69B|ERI3|PTCH2|B4GALT2|RLF|RPS8|SFPQ|TRIT1|RHBDL2|ADPRS|YARS1|PABPC4-AS1|SZT2|MACF1|A3GALT2|PPT1|PSMB2|PTPRF|ST3GAL3|PIK3R3|PABPC4|NASP|NDUFS5|SMAP2|S100PBP|HEYL|AGO1|C1orf216|KLF17|RIMKLA|TFAP2E|DLGAP3|BEST4|RSPO1|MMACHC|MYCBP|EPHA10		Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000584069	1	33241563 - 46663513			584069	556486		
NM_002764.4(PRPS1):c.*938dup	PRPS1		Phosphoribosylpyrophosphate synthetase superactivity|Arts syndrome|Charcot-Marie-Tooth, X-linked|Nonsyndromic Hearing Loss, X-Linked	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000367712	X	106894194 - 106894195	X	107650964 - 107650965	367712	351943	rs1057515728	NC_000023.11:107650964:AAAAAA:AAAAAAA
NM_181882.3(PRX):c.1490_1491delinsTG (p.Pro497Leu)	PRX	P497L	Charcot-Marie-Tooth disease	Uncertain significance	criteria provided, single submitter	VCV000917169	19	40902768 - 40902769	19	40396861 - 40396862	917169	905473		NC_000019.10:40396860:GG:CA
NM_181882.3(PRX):c.122_124delinsAAGCTGCGCGAGGAAGCTGC (p.Gly41fs)	PRX	G41fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000916820	19	40909673 - 40909675	19	40403766 - 40403768	916820	905489		NC_000019.10:40403765:TTC:GCAGCTTCCTCGCGCAGCTT
NM_181882.3(PRX):c.121_122insAAGCTGCGCGAG (p.Gly41_Ile42insGluAlaAlaArg)	PRX		Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000916818	19	40909675 - 40909676	19	40403768 - 40403769	916818	905491		NC_000019.10:40403768:C:CTCGCGCAGCTTC
NM_181882.3(PRX):c.124_125insGCTGC (p.Ile42fs)	PRX	I42fs	Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000916817	19	40909672 - 40909673	19	40403765 - 40403766	916817	905488		NC_000019.10:40403765::GCAGC
NM_181882.3(PRX):c.2615dup (p.Ala873fs)	PRX	A873fs	Charcot-Marie-Tooth disease, type I	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694915	19	40901643 - 40901644	19	40395736 - 40395737	694915	683098	rs374001049	NC_000019.10:40395736:GGG:GGGG
NM_181882.3(PRX):c.165_177dup (p.Gln60fs)	PRX	Q60fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000649369	19	40909619 - 40909620	19	40403712 - 40403713	649369	648135	rs1599662669	NC_000019.10:40403712:CAGGCTGAGGCTCC:CAGGCTGAGGCTCCAGGCTGAGGCTCC
NM_181882.3(PRX):c.642dup (p.Arg215fs)	PRX	R215fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637943	19	40903616 - 40903617	19	40397709 - 40397710	637943	625435	rs768074428	NC_000019.10:40397709:GGGGGG:GGGGGGG
NM_181882.3(PRX):c.385_394dup (p.Leu132fs)	PRX	L132fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 4F	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000637915	19	40903864 - 40903865	19	40397957 - 40397958	637915	625437	rs1599656972	NC_000019.10:40397957:GACTCTGGATG:GACTCTGGATGACTCTGGATG
NM_181882.3(PRX):c.3772_3773delinsA (p.Gly1258fs)	PRX	G1258fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637848	19	40900486 - 40900487	19	40394579 - 40394580	637848	625416	rs1599650427	NC_000019.10:40394578:CC:T
NM_181882.3(PRX):c.915_923dup (p.305TLP[3])	PRX		Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637492	19	40903335 - 40903336	19	40397428 - 40397429	637492	625431	rs1170437868	NC_000019.10:40397428:GTGGGCAGAGTGGGCAG:GTGGGCAGAGTGGGCAGAGTGGGCAG
NM_181882.3(PRX):c.773_774dup (p.Ser259fs)	PRX	S259fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV000637397	19	40903484 - 40903485	19	40397577 - 40397578	637397	625433	rs1599656136	NC_000019.10:40397577:GGGGG:GGGGGGG
NM_181882.3(PRX):c.124_125dup (p.Phe43fs)	PRX	F43fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637392	19	40909671 - 40909672	19	40403764 - 40403765	637392	625439	rs1599662837	NC_000019.10:40403764:AT:ATAT
NC_000003.12:g.(?_128795358)_(128813432_?)dup	RAB7A		Charcot-Marie-Tooth disease type 2B	Uncertain significance(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000833207	3	128514201 - 128532275			833207	819321		
NM_001354689.3(RAF1):c.321-14dup	RAF1		not provided|Noonan syndrome with multiple lentigines|Noonan syndrome|not specified|none provided	Benign/Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000044625	3	12650847 - 12650848	3	12609348 - 12609349	44625	53792	rs202103447	NC_000003.12:12609348:AAAAAAAA:AAAAAAAAA
NM_002906.4(RDX):c.1405dup (p.Ala469fs)	RDX	A333fs, A122fs, A469fs	Deafness, autosomal recessive 24	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000013185	11	110104143 - 110104144	11	110233418 - 110233419	13185	28224	rs1372141763	NC_000011.10:110233418:C:CC
NM_003730.6(RNASET2):c.710dup (p.Leu238fs)	RNASET2	L238fs	Leukoencephalopathy, cystic, without megalencephaly	Likely pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000436545	6	167343136 - 167343137	6	166929648 - 166929649	436545	428599	rs763295910	NC_000006.12:166929648:CCCC:CCCCC
NM_001024630.4(RUNX2):c.1205dup (p.Pro403fs)	RUNX2	P389fs, P403fs, P367fs, P381fs	Cleidocranial dysplasia, severe, with osteoporosis and scoliosis	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000009301	6	45514677 - 45514678	6	45546940 - 45546941	9301	24340	rs730880314	NC_000006.12:45546940:CCCC:CCCCC
NM_002968.3(SALL1):c.2287dup (p.Arg763fs)	SALL1	R666fs, R763fs	Townes-Brocks syndrome 1	Likely pathogenic(Last reviewed: Oct 4, 2019)	no assertion criteria provided	VCV000830013	16	51173845 - 51173846	16	51139934 - 51139935	830013	818328	rs1597229151	NC_000016.10:51139934:T:TT
NM_002968.3(SALL1):c.2686_2689dup (p.Val897fs)	SALL1	V897fs, V800fs	Townes-Brocks syndrome 1	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000807481	16	51173443 - 51173444	16	51139532 - 51139533	807481	798700	rs1597228568	NC_000016.10:51139532:CATCC:CATCCATCC
NM_002968.3(SALL1):c.*1033dup	SALL1		Townes-Brocks syndrome 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319576	16	51169989 - 51169990	16	51136078 - 51136079	319576	335246	rs551604859	NC_000016.10:51136078:CCCCCCC:CCCCCCCC
NM_002968.3(SALL1):c.*1112dup	SALL1		Townes-Brocks syndrome 1	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319575	16	51169910 - 51169911	16	51135999 - 51136000	319575	341726	rs551203456	NC_000016.10:51135999:AAAAAAAA:AAAAAAAAA
NM_020436.5(SALL4):c.827dup (p.Ser276fs)	SALL4	S276fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000571934	20	50408194 - 50408195	20	51791655 - 51791656	571934	575119	rs1568865283	NC_000020.11:51791655:C:CC
NM_020436.5(SALL4):c.496dup (p.Gln166fs)	SALL4	Q166fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000177616	20	50408525 - 50408526	20	51791986 - 51791987	177616	178178	rs797044509	NC_000020.11:51791986:GGGGGG:GGGGGGG
NM_020436.5(SALL4):c.941dup (p.Leu315fs)	SALL4	L315fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000003320	20	50408080 - 50408081	20	51791541 - 51791542	3320	18359	rs1601170799	NC_000020.11:51791541:G:GG
NM_030962.4(SBF2):c.142-14dup	SBF2		not provided|Charcot-Marie-Tooth disease	Likely benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000917184	11	10064541 - 10064542	11	10042994 - 10042995	917184	905630		NC_000011.10:10042994:AAAAAAAAA:AAAAAAAAAA
NM_001365536.1(SCN9A):c.4026delinsTT (p.Leu1342fs)	SCN9A|SCN1A-AS1	L1331fs, L1342fs	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IID|Charcot-Marie-Tooth disease	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2013)	no assertion criteria provided	VCV000157598	2	167085381	2	166228871	157598	167459	rs606231279	NC_000002.12:166228870:C:AA
NM_012431.3(SEMA3E):c.2303dup (p.Pro769fs)	SEMA3E	P709fs, P769fs	CHARGE association	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001059922	7	82996926 - 82996927	7	83367610 - 83367611	1059922	1045123		NC_000007.14:83367610:A:AA
NM_001113491.2(SEPTIN9):c.913+62_913+64delinsAGT	SEPTIN9		Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694904	17	75478479 - 75478481	17	77482397 - 77482399	694904	683128	rs1598444764	NC_000017.11:77482396:GGC:AGT
NM_032861.4(SERAC1):c.1850_1851insA (p.Pro618fs)	SERAC1	P618fs	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic	no assertion criteria provided	VCV001184550	6	158532512 - 158532513	6	158111480 - 158111481	1184550	1174282		NC_000006.12:158111480::T
NM_032861.4(SERAC1):c.1823dup (p.Ala609fs)	SERAC1	A609fs	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000938842	6	158534485 - 158534486	6	158113453 - 158113454	938842	933241		NC_000006.12:158113453:G:GG
NM_032861.4(SERAC1):c.1643_1646dup (p.Leu550fs)	SERAC1	L550fs	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Pathogenic	no assertion criteria provided	VCV000430608	6	158535858 - 158535859	6	158114826 - 158114827	430608	423256	rs761964407	NC_000006.12:158114826:AGATAG:AGATAGATAG
NM_032861.4(SERAC1):c.262_265dup (p.Gly89fs)	SERAC1	G89fs	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Likely pathogenic(Last reviewed: Sep 28, 2014)	criteria provided, single submitter	VCV000208610	6	158571484 - 158571485	6	158150452 - 158150453	208610	205195	rs797045105	NC_000006.12:158150452:CATG:CATGCATG
NM_024577.4(SH3TC2):c.822_850dup (p.Lys284delinsArgProTer)	SH3TC2		Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000916949	5	148418008 - 148418009	5	149038445 - 149038446	916949	905167		NC_000005.10:149038445:TTTCTCCTGGCTCATAACCCGTCAAGGCCTT:TTTCTCCTGGCTCATAACCCGTCAAGGCCTTTCTCCTGGCTCATAACCCGTCAAGGCCTT
NM_024577.4(SH3TC2):c.2551_2554dup (p.Val852fs)	SH3TC2	V852fs	Charcot-Marie-Tooth disease	Likely pathogenic	criteria provided, single submitter	VCV000916842	5	148406740 - 148406741	5	149027177 - 149027178	916842	905143		NC_000005.10:149027177:CCCG:CCCGCCCG
NM_024577.4(SH3TC2):c.54dup (p.Lys19Ter)	SH3TC2	K19*	Charcot-Marie-Tooth disease, type 4C|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000694979	5	148431801 - 148431802	5	149052238 - 149052239	694979	682994	rs1580917136	NC_000005.10:149052238:A:AA
NM_024577.4(SH3TC2):c.280-1334dup	SH3TC2		Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694978	5	148425526 - 148425527	5	149045963 - 149045964	694978	683116	rs752479043	NC_000005.10:149045963:AAAAAAAAA:AAAAAAAAAA
NM_024577.4(SH3TC2):c.3295dup (p.Arg1099fs)	SH3TC2	R1099fs	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694969	5	148389864 - 148389865	5	149010301 - 149010302	694969	682987	rs1580889900	NC_000005.10:149010301:GGG:GGGG
NM_024577.4(SH3TC2):c.*861dup	SH3TC2		Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Aug 14, 2019)	no assertion criteria provided	VCV000694968	5	148383412 - 148383413	5	149003849 - 149003850	694968	682986	rs5872107	NC_000005.10:149003849:AAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAA
NM_024577.4(SH3TC2):c.1894_1897delinsAAA (p.Glu632fs)	SH3TC2	E632fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637411	5	148407398 - 148407401	5	149027835 - 149027838	637411	625124	rs1580900758	NC_000005.10:149027834:CCTC:TTT
NM_024577.4(SH3TC2):c.1194_1195delinsCC (p.Phe399Leu)	SH3TC2	F399L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV000476882	5	148408100 - 148408101	5	149028537 - 149028538	476882	455294	rs1554121791	NC_000005.10:149028536:AA:GG
NM_024577.4(SH3TC2):c.1402_1403delinsTT	SH3TC2	A468F	Charcot-Marie-Tooth disease type 4|Distal spinal muscular atrophy|not provided|Hereditary spastic paraplegia|not specified|Charcot-Marie-Tooth disease|Toe walking	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2021)	criteria provided, conflicting interpretations	VCV000216737	5	148407892 - 148407893	5	149028329 - 149028330	216737	212511	rs863224780	NC_000005.10:149028328:GC:AA
NM_024577.4(SH3TC2):c.217_227delinsCCAGTAA (p.Ala73fs)	SH3TC2	A73fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000021692	5	148427477 - 148427487	5	149047914 - 149047924	21692	34544		NC_000005.10:149047913:CTCCGAGCAGC:TTACTGG
NC_000014.8:g.(?_60976117)_(61191013_?)dup	SIX4|SIX6|SIX1		Branchiootic syndrome 3|Deafness, autosomal dominant 23|not provided	Uncertain significance(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000999901	14	60976117 - 61191013			999901	986525		
NM_001365088.1(SLC12A6):c.2028_2029insT (p.Arg677fs)	SLC12A6	R618fs, R662fs, R677fs, R626fs, R668fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637872	15	34536188 - 34536189	15	34243987 - 34243988	637872	625309	rs1595415679	NC_000015.10:34243987::A
NM_001365088.1(SLC12A6):c.250dup (p.His84fs)	SLC12A6	H84fs, H25fs, H75fs	Agenesis of the corpus callosum with peripheral neuropathy	Pathogenic(Last reviewed: Oct 21, 2014)	no assertion criteria provided	VCV000374347	15	34628631 - 34628632	15	34336430 - 34336431	374347	361213	rs1057518713	NC_000015.10:34336430:G:GG
NM_139319.3(SLC17A8):c.616dup (p.Met206fs)	SLC17A8	M206fs	Deafness, autosomal dominant 25	Pathogenic(Last reviewed: May 12, 2021)	no assertion criteria provided	VCV001077163	12	100790134 - 100790135	12	100396356 - 100396357	1077163	1065824		NC_000012.12:100396356:A:AA
NM_006996.3(SLC19A2):c.205-25_205-24dup	SLC19A2		Thiamine-responsive megaloblastic anemia|Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293533	1	169447008 - 169447009	1	169477770 - 169477771	293533	277132	rs755410874	NC_000001.11:169477770:AAAAAAAAAAAA:AAAAAAAAAAAAAA
NM_006996.3(SLC19A2):c.205-25dup	SLC19A2		not provided|Thiamine-responsive megaloblastic anemia|Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2019)	criteria provided, conflicting interpretations	VCV000293532	1	169447008 - 169447009	1	169477770 - 169477771	293532	277399	rs755410874	NC_000001.11:169477770:AAAAAAAAAAAA:AAAAAAAAAAAAA
NM_006996.3(SLC19A2):c.*712dup	SLC19A2		Thiamine-responsive megaloblastic anemia|Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293515	1	169434374 - 169434375	1	169465136 - 169465137	293515	278186	rs886045526	NC_000001.11:169465136:AAA:AAAA
NM_006996.3(SLC19A2):c.242dup (p.Tyr81Ter)	SLC19A2	Y81*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005961	1	169446957 - 169446958	1	169477719 - 169477720	5961	21000	rs752104654	NC_000001.11:169477719:T:TT
NM_000441.2(SLC26A4):c.1299dup (p.Ala434fs)	SLC26A4	A434fs	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	no assertion criteria provided	VCV001065213	7	107334882 - 107334883	7	107694437 - 107694438	1065213	1053522		NC_000007.14:107694437:C:CC
NM_000441.2(SLC26A4):c.2174_2177dup (p.Leu727fs)	SLC26A4	L727fs	Pendred syndrome|not provided	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV000851431	7	107350582 - 107350583	7	107710137 - 107710138	851431	832780		NC_000007.14:107710137:CTAT:CTATCTAT
NM_000441.2(SLC26A4):c.1458dup (p.Ile487fs)	SLC26A4	I487fs	Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic	criteria provided, single submitter	VCV000813397	7	107336397 - 107336398	7	107695952 - 107695953	813397	801644	rs1584331188	NC_000007.14:107695952:T:TT
NM_000441.2(SLC26A4):c.1692dup (p.Cys565fs)	SLC26A4	C565fs	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic(Last reviewed: Jun 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000627475	7	107340599 - 107340600	7	107700154 - 107700155	627475	615802	rs746427774	NC_000007.14:107700154:AAAAAA:AAAAAAA
NM_000441.1(SLC26A4):c.(?_305)_(415_?)dup (p.(?))	SLC26A4		Rare genetic deafness	Likely pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000517189	7	107312583 - 107312693	7	107672138 - 107672248	517189	496878		
NM_000441.2(SLC26A4):c.2106_2110dup (p.Glu704fs)	SLC26A4	E704fs	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446458	7	107350514 - 107350515	7	107710069 - 107710070	446458	439910	rs1554362735	NC_000007.14:107710069:GCTGG:GCTGGGCTGG
NM_000441.2(SLC26A4):c.1651dup (p.Ser551fs)	SLC26A4	S551fs	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000446455	7	107340560 - 107340561	7	107700115 - 107700116	446455	439904	rs1554360678	NC_000007.14:107700115:TTTT:TTTTT
NM_000441.2(SLC26A4):c.916dup (p.Val306fs)	SLC26A4	V306fs	Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370192	7	107323796 - 107323797	7	107683351 - 107683352	370192	357534	rs768245266	NC_000007.14:107683351:G:GG
NM_000441.2(SLC26A4):c.*1584dup	SLC26A4		Pendred syndrome|Nonsyndromic Hearing Loss, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000358521	7	107357474 - 107357475	7	107717029 - 107717030	358521	309466	rs886061890	NC_000007.14:107717029:A:AA
NM_000441.2(SLC26A4):c.365dup (p.Ile124fs)	SLC26A4	I124fs	Pendred syndrome|not provided	Pathogenic(Last reviewed: Sep 10, 2018)	reviewed by expert panel	VCV000189148	7	107312637 - 107312638	7	107672192 - 107672193	189148	186730	rs786204730	NC_000007.14:107672192:TTTTTT:TTTTTTT
NM_000441.2(SLC26A4):c.1547dup (p.Ser517fs)	SLC26A4	S517fs	not provided|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188759	7	107338487 - 107338488	7	107698042 - 107698043	188759	186736	rs786204450	NC_000007.14:107698042:CC:CCC
NM_000441.2(SLC26A4):c.397_398delinsA (p.Ser133fs)	SLC26A4	S133fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Sep 19, 2008)	criteria provided, single submitter	VCV000043556	7	107312675 - 107312676	7	107672230 - 107672231	43556	52725	rs111033400	NC_000007.14:107672229:TC:A
NM_000441.2(SLC26A4):c.1548_1549insC (p.Ser517fs)	SLC26A4	S517fs	Rare genetic deafness	Likely pathogenic(Last reviewed: Mar 7, 2007)	criteria provided, single submitter	VCV000043514	7	107338490 - 107338491	7	107698045 - 107698046	43514	52683	rs111033317	NC_000007.14:107698045::C
NM_000441.1(SLC26A4):c.1342-2_1343dup	SLC26A4		Rare genetic deafness|not provided	Pathogenic(Last reviewed: Mar 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043506	7	107335064 - 107335067	7	107694617 - 107694618	43506	52676	rs111033407	NC_000007.14:107694617:CAGTC:CAGTCAGTC
NM_000441.2(SLC26A4):c.2182_2183insG (p.Tyr728Ter)	SLC26A4	Y728*	Pendred syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000004832	7	107350591 - 107350592	7	107710146 - 107710147	4832	19871	rs1584344687	NC_000007.14:107710146::G
SLC26A4, 5-BP INS, NT2111	SLC26A4		Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000004824					4824	19863		
NM_198999.3(SLC26A5):c.292+8_292+9insGA	SLC26A5		Deafness, autosomal recessive 61	Likely benign(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000994043	7	103061176 - 103061177	7	103420729 - 103420730	994043	981566		NC_000007.14:103420729::TC
NM_018344.6(SLC29A3):c.303_320dup (p.Tyr102_Leu107dup)	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Uncertain significance(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000934211	10	73103967 - 73103968	10	71344210 - 71344211	934211	935150		NC_000010.11:71344210:CTACTTTGAGAGCTACCT:CTACTTTGAGAGCTACCTCTACTTTGAGAGCTACCT
NM_018344.6(SLC29A3):c.383+7_383+8delinsAG	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Likely benign(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000741771	10	73104055 - 73104056	10	71344298 - 71344299	741771	759960	rs1589232669	NC_000010.11:71344297:GA:AG
NM_018344.6(SLC29A3):c.914_915delinsTC (p.Thr305Ile)	SLC29A3	T227I, T305I	Histiocytosis-lymphadenopathy plus syndrome	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000655961	10	73121851 - 73121852	10	71362094 - 71362095	655961	639136	rs1589244189	NC_000010.11:71362093:CG:TC
NC_000010.10:g.(?_73079047)_(73082831_?)dup	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000583783	10	73079047 - 73082831	10	71319290 - 71323074	583783	569414		
NM_018344.6(SLC29A3):c.*657dup	SLC29A3		Histiocytosis-lymphadenopathy plus syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000300383	10	73123015 - 73123016	10	71363258 - 71363259	300383	322642	rs564371527	NC_000010.11:71363258:AAAAAAA:AAAAAAAA
SLC4A11, 8-BP DUP, NT2233	SLC4A11		Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001317					1317	16356		
NM_001174089.2(SLC4A11):c.1330_1333delinsA (p.Tyr444_Ala445delinsThr)	SLC4A11		Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001313	20	3211243 - 3211246	20	3230597 - 3230600	1313	16352	rs869320722	NC_000020.11:3230596:CGTA:T
NC_000020.10:g.741847_741848insCTGAGGCAGCCGCTGAAAAGCACCCACGAGGCCACCTGCGGGGCCGGGAGGGAAGCGTAG	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV001045260	20	741847 - 741848	20	761203 - 761204	1045260	1034831		
NM_033409.4(SLC52A3):c.1327_1338dup (p.Gly443_Leu446dup)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000937442	20	741741 - 741742	20	761097 - 761098	937442	939058		NC_000020.11:761097:GAGCAGCGCTCCGAGCAGCG:GAGCAGCGCTCCGAGCAGCGCTCCGAGCAGCG
NC_000020.10:g.(?_741650)_(746438_?)dup	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000652376	20	741650 - 746438	20	761006 - 765794	652376	653643		
NM_033409.4(SLC52A3):c.1403_1404insTGCCTTCTGCAATCTGCACTGTCC (p.Phe462_Ala469dup)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000651312	20	741676 - 741677	20	761032 - 761033	651312	648849	rs1599955591	NC_000020.11:761032:GGACAGTGCAGATTGCAGAAG:GGACAGTGCAGATTGCAGAAGGCAGGACAGTGCAGATTGCAGAAG
NM_033409.4(SLC52A3):c.568-16_568-15insCTGATTGAC	SLC52A3		not provided|Brown-Vialetto-Van Laere syndrome 1|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000262235	20	744662 - 744663	20	764018 - 764019	262235	257437	rs3833341	NC_000020.11:764018:CAG:CAGGTCAATCAG
NM_014332.3(SMPX):c.87dup (p.Gly30fs)	SMPX	G30fs	Deafness, X-linked	Pathogenic(Last reviewed: Oct 1, 2017)	no assertion criteria provided	VCV000444056	X	21761912 - 21761913	X	21743794 - 21743795	444056	437698	rs1569308571	NC_000023.11:21743794:T:TT
NM_005634.3(SOX3):c.735_737dup (p.Ala248dup)	SOX3		Mental retardation with panhypopituitarism, X-linked|not provided|Cognitive impairment|Abnormality of the tongue|Pectus excavatum|Acute myeloid leukemia|Pancytopenia|Webbed neck|Short stature|Sensorineural hearing loss|Global developmental delay|Bilateral cleft lip and palate|Autistic disorder of childhood onset|Pulmonic stenosis|Bilateral cleft lip|Unilateral renal agenesis|Cryptorchidism|Strabismus|Scoliosis|Hemivertebrae|Renal agenesis|Cleft palate|Relative macrocephaly|Severe visual impairment|Abnormality of the sternum|Bilateral cleft palate|Delayed speech and language development|Rib fusion	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000095305	X	139586488 - 139586489	X	140504323 - 140504324	95305	101204	rs398124211	NC_000023.11:140504323:GCGGC:GCGGCGGC
NM_001124758.2(SPNS2):c.c.1066_1067delinsT (p.Pro356Cysfs)	SPNS2	P356fs	Deafness, autosomal recessive 115|Inborn genetic diseases	Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000521864	17	4436402 - 4436403	17	4533107 - 4533108	521864	512292	rs1555537637	NC_000017.11:4533106:CC:T
NM_153700.2(STRC):c.4917_4918delinsCT (p.Leu1640Phe)	STRC		Deafness, autosomal recessive 16|not provided|not specified	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000165301	15	43892807 - 43892808	15	43600609 - 43600610	165301	176105	rs727503441	NC_000015.10:43600608:GT:AG
NM_153700.2(STRC):c.3156dup (p.Cys1053fs)	STRC	C1053fs	Deafness, autosomal recessive 16	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004343	15	43903495 - 43903496	15	43611297 - 43611298	4343	19382	rs786200882	NC_000015.10:43611297:G:GG
NM_001199107.2(TBC1D24):c.76_77delinsTT (p.Glu26Leu)	TBC1D24	E26L	Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65	Uncertain significance(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV001026209	16	2546225 - 2546226	16	2496224 - 2496225	1026209	1012056		NC_000016.10:2496223:GA:TT
NC_000016.9:g.(?_2546130)_(2550979_?)dup	TBC1D24		Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000655213	16	2546130 - 2550979	16	2496129 - 2500978	655213	653128		
NM_001199107.2(TBC1D24):c.*3478dup	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318685	16	2554415 - 2554416	16	2504414 - 2504415	318685	342590	rs901354911	NC_000016.10:2504414:TTTTTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTT
NM_001199107.2(TBC1D24):c.*2875dup	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318676	16	2553832 - 2553833	16	2503831 - 2503832	318676	341046	rs886051864	NC_000016.10:2503831:TT:TTT
NM_001199107.2(TBC1D24):c.*2851dup	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318671	16	2553802 - 2553803	16	2503801 - 2503802	318671	342575	rs376511845	NC_000016.10:2503801:CCCCCCCC:CCCCCCCCC
NM_001199107.2(TBC1D24):c.*2834_*2835insA	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318670	16	2553793 - 2553794	16	2503792 - 2503793	318670	334470	rs548778667	NC_000016.10:2503792::A
NM_001199107.2(TBC1D24):c.*2624_*2625dup	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318666	16	2553570 - 2553571	16	2503569 - 2503570	318666	324858	rs35944492	NC_000016.10:2503569:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT
NM_001199107.2(TBC1D24):c.*2625dup	TBC1D24		Myoclonic epilepsy, familial infantile	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318665	16	2553570 - 2553571	16	2503569 - 2503570	318665	324860	rs35944492	NC_000016.10:2503569:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_001199107.2(TBC1D24):c.1460dup (p.His487fs)	TBC1D24	H481fs, H487fs	DOORS syndrome	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000183156	16	2550425 - 2550426	16	2500424 - 2500425	183156	181293	rs797044549	NC_000016.10:2500424:A:AA
NM_005422.4(TECTA):c.840_841insT (p.Val281fs)	TBCEL-TECTA|TECTA	V281fs, V600fs	Deafness, autosomal recessive 21|Deafness, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562087	11	120989064 - 120989065	11	121118355 - 121118356	562087	553262	rs1565519673	NC_000011.10:121118355::T
NM_005422.4(TECTA):c.651dup (p.Asn218fs)	TECTA|TBCEL-TECTA	N218fs, N537fs	Deafness, neurosensory autosomal recessive 21	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000007018	11	120984286 - 120984287	11	121113577 - 121113578	7018	22057	rs1591437831	NC_000011.10:121113577:CC:CCC
9q21.11 duplication	TJP2		Deafness, autosomal dominant 51	Pathogenic(Last reviewed: Nov 24, 2019)	no assertion criteria provided	VCV000813832					813832	802084		
NC_000009.11:g.71705804_71974823invdup	TJP2		Deafness, autosomal dominant 51	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236063					236063	237628		
NC_000009.11:g.71704982_71840362dup	TJP2		Deafness, autosomal dominant 51	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236035	9	71704982 - 71840362	9	69090066 - 69225446	236035	237603		
NM_138691.3(TMC1):c.1220dup (p.Asn407fs)	TMC1	N407fs	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562091	9	75404222 - 75404223	9	72789306 - 72789307	562091	553260	rs1564555185	NC_000009.12:72789306:AAAAAAA:AAAAAAAA
NM_138691.3(TMC1):c.15dup (p.Val6fs)	TMC1	V6fs	Deafness, autosomal recessive 7	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236041	9	75263573 - 75263574	9	72648657 - 72648658	236041	237604	rs878853229	NC_000009.12:72648657:AAAAAA:AAAAAAA
NM_138691.3(TMC1):c.215_219dup (p.Arg74fs)	TMC1	R74fs	Rare genetic deafness	Pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	VCV000179431	9	75309608 - 75309609	9	72694692 - 72694693	179431	178278	rs730880359	NC_000009.12:72694692:GGAGG:GGAGGGGAGG
NM_147196.3(TMIE):c.122_125dup (p.Pro43fs)	TMIE	P43fs	Sensorineural hearing loss	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV000984396	3	46747306 - 46747307	3	46705816 - 46705817	984396	972460		NC_000003.12:46705816:CCGCC:CCGCCCGCC
NM_147196.3(TMIE):c.94-2_98delinsC	TMIE		Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000003393	3	46747278 - 46747284	3	46705788 - 46705794	3393	18432	rs876657371	NC_000003.12:46705787:AGCCCAG:C
NM_001256317.3(TMPRSS3):c.617-3_617-2insTA	TMPRSS3		Deafness, autosomal recessive 8	Benign(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000810903	21	43803309 - 43803310	21	42383200 - 42383201	810903	800176	rs1601523730	NC_000021.9:42383200::TA
NM_001256317.3(TMPRSS3):c.579dup (p.Cys194fs)	TMPRSS3	C194fs, C67fs	Hearing impairment|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000517148	21	43804115 - 43804116	21	42384006 - 42384007	517148	497344	rs397517376	NC_000021.9:42384006:T:TT
TMPRSS3, 8-BP DEL, SATELLITE REPEAT INS	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000004942					4942	19981		
TNFRSF11B, 3-BP DEL AND 2-BP INS	TNFRSF11B		Hyperphosphatasemia with bone disease	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000006972					6972	22011		
NM_001065.4(TNFRSF1A):c.362_363insTGCAAGACACAG (p.Asp122_Thr123insAlaArgHisArg)	TNFRSF1A		CHARGE association	Pathogenic(Last reviewed: Nov 13, 2019)	no assertion criteria provided	VCV000800355	12	6442642 - 6442643	12	6333476 - 6333477	800355	788954	rs1592047560	NC_000012.12:6333476:C:CTGTGTCTTGCAC
NM_001128228.3(TPRN):c.227_237dup (p.Leu80fs)	TPRN	L80fs	Deafness, autosomal recessive 79	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000000136	9	140094926 - 140094927	9	137200474 - 137200475	136	15175	rs387906220	NC_000009.12:137200474:CAGCCGCGCCCC:CAGCCGCGCCCCAGCCGCGCCCC
NM_001039141.3(TRIOBP):c.3232dup (p.Arg1078fs)	TRIOBP	R1078fs	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV001034395	22	38121788 - 38121789	22	37725781 - 37725782	1034395	1022105		NC_000022.11:37725781:CCCCCCC:CCCCCCCC
NM_021625.5(TRPV4):c.1152+15dup	TRPV4		Charcot-Marie-Tooth disease	Likely benign	criteria provided, single submitter	VCV000917312	12	110236399 - 110236400	12	109798594 - 109798595	917312	905664		NC_000012.12:109798594:CCCCC:CCCCCC
NM_153676.4(USH1C):c.1146dup (p.Gln383fs)	USH1C	Q364fs, Q383fs	not provided|Usher syndrome, type 1C|Deafness, autosomal recessive 18	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000555436	11	17542480 - 17542481	11	17520933 - 17520934	555436	546386	rs1554960388	NC_000011.10:17520933:TT:TTT
NM_153676.4(USH1C):c.2326dup (p.Ile776fs)	USH1C	I457fs, I776fs, I476fs	not provided|Deafness, autosomal recessive 18|Usher syndrome, type 1C	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555137	11	17522651 - 17522652	11	17501104 - 17501105	555137	546225	rs758555088	NC_000011.10:17501104:T:TT
NM_153676.4(USH1C):c.1559dup (p.Ser521fs)	USH1C	S521fs	Deafness, autosomal recessive 18|Usher syndrome, type 1C|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 24, 2018)	criteria provided, conflicting interpretations	VCV000553953	11	17531356 - 17531357	11	17509809 - 17509810	553953	546376	rs1554957167	NC_000011.10:17509809:GG:GGG
NM_153676.4(USH1C):c.*419_*420insAACA	USH1C		Nonsyndromic Hearing Loss, Recessive|Retinitis pigmentosa-deafness syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303793	11	17515459 - 17515460	11	17493912 - 17493913	303793	325652	rs10626485	NC_000011.10:17493912:T:TGTTT
NM_153676.4(USH1C):c.238dup (p.Arg80fs)	USH1C	R80fs	Rare genetic deafness|Usher syndrome|not provided|Deafness, autosomal recessive|Retinitis pigmentosa|Retinal dystrophy|Usher syndrome, type 1C|Deafness, autosomal recessive 18|Usher syndrome type 1	Pathogenic(Last reviewed: Jun 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005141	11	17552955 - 17552956	11	17531408 - 17531409	5141	20180	rs397515359	NC_000011.10:17531408:GGGGGG:GGGGGGG
NM_173477.5(USH1G):c.208_209insTC (p.His70fs)	USH1G	H70fs	not provided|Usher syndrome type 1	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000493220	17	72916722 - 72916723	17	74920627 - 74920628	493220	486183	rs1555627787	NC_000017.11:74920627:G:GAG
NM_173477.5(USH1G):c.*1903_*1905dup	USH1G		Retinitis pigmentosa-deafness syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000325029	17	72912259 - 72912260	17	74916167 - 74916168	325029	329796	rs886053382	NC_000017.11:74916167:CTGCT:CTGCTGCT
NM_173477.5(USH1G):c.394dup (p.Val132fs)	USH1G	V29fs, V132fs	Usher syndrome type 1|Usher syndrome, type 1G	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000002917	17	72916536 - 72916537	17	74920441 - 74920442	2917	17956	rs587776546	NC_000017.11:74920441:CC:CCC
NM_206933.4(USH2A):c.13465_13466insTG (p.Gly4489fs)	USH2A	G4489fs	Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000917733	1	215847787 - 215847788	1	215674445 - 215674446	917733	906121		NC_000001.11:215674445:C:CAC
NM_206933.4(USH2A):c.4189_4193dup (p.Ile1399fs)	USH2A|USH2A-AS1	I1399fs	Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness	Likely pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554392	1	216369952 - 216369953	1	216196610 - 216196611	554392	540927	rs1553313308	NC_000001.11:216196610:TCATA:TCATATCATA
NM_206933.2(USH2A):c.11048-?_11711+?dup	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000503553	1	215914717 - 215933185			503553	494951		
NM_206933.4(USH2A):c.1992dup (p.Lys665Ter)	USH2A	K665*	Rare genetic deafness	Pathogenic(Last reviewed: May 31, 2013)	criteria provided, single submitter	VCV000178971	1	216424419 - 216424420	1	216251077 - 216251078	178971	172778	rs730880349	NC_000001.11:216251077:A:AA
NM_206933.4(USH2A):c.4510dup (p.Arg1504fs)	USH2A	R1504fs	Retinal dystrophy|not provided|Retinitis pigmentosa|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|Usher syndrome	Pathogenic(Last reviewed: Sep 10, 2018)	reviewed by expert panel	VCV000166504	1	216348710 - 216348711	1	216175368 - 216175369	166504	172390	rs727503731	NC_000001.11:216175368:TTT:TTTT
NM_206933.4(USH2A):c.920_923dup (p.His308fs)	USH2A	H308fs	Rare genetic deafness|Usher syndrome|Retinitis pigmentosa 39|Retinal dystrophy|Retinitis pigmentosa|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Oct 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000048615	1	216498866 - 216498867	1	216325524 - 216325525	48615	57777	rs397518043	NC_000001.11:216325524:TGGCTG:TGGCTGGCTG
NM_206933.4(USH2A):c.5001dup (p.Gly1668fs)	USH2A|USH2A-AS2	G1668fs	Rare genetic deafness	Pathogenic(Last reviewed: Mar 11, 2013)	criteria provided, single submitter	VCV000048526	1	216258205 - 216258206	1	216084863 - 216084864	48526	57688	rs397518018	NC_000001.11:216084863:TTTTT:TTTTTT
NM_206933.4(USH2A):c.14031dup (p.Ala4678fs)	USH2A	A4678fs	not provided|Rare genetic deafness	Pathogenic(Last reviewed: Sep 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048426	1	215844415 - 215844416	1	215671073 - 215671074	48426	57588	rs397517988	NC_000001.11:215671073:T:TT
NM_152564.5(VPS13B):c.4286_4287insT (p.Ala1431fs)	VPS13B	A1431fs, A1456fs	Cohen syndrome	Likely pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001217354	8	100523393 - 100523394	8	99511165 - 99511166	1217354	1207338		NC_000008.11:99511165::T
NM_152564.5(VPS13B):c.11495+3_11495+34dup	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001109442	8	100883116 - 100883117	8	99870888 - 99870889	1109442	1097410		NC_000008.11:99870888:TAAAATTATTGAGATACGTGCTCAACTTTACAT:TAAAATTATTGAGATACGTGCTCAACTTTACATAAAATTATTGAGATACGTGCTCAACTTTACAT
NM_152564.5(VPS13B):c.11495+10_11495+11delinsAC	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV001095807	8	100883125 - 100883126	8	99870897 - 99870898	1095807	1075740		NC_000008.11:99870896:TT:AC
NM_152564.5(VPS13B):c.6140dup (p.Asn2047fs)	VPS13B	N2047fs, N2072fs	Cohen syndrome	Pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV001076736	8	100711840 - 100711841	8	99699612 - 99699613	1076736	1061468		NC_000008.11:99699612:AAAAAA:AAAAAAA
NM_152564.5(VPS13B):c.1755_1759dup (p.Asp587fs)	VPS13B	D587fs	Cohen syndrome	Pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001076170	8	100155303 - 100155304	8	99143075 - 99143076	1076170	1061456		NC_000008.11:99143075:GTTTGG:GTTTGGTTTGG
NM_152564.5(VPS13B):c.11725dup (p.Arg3909fs)	VPS13B	R3909fs, R3934fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001075811	8	100883903 - 100883904	8	99871675 - 99871676	1075811	1061486		NC_000008.11:99871675:AA:AAA
NM_152564.5(VPS13B):c.2989dup (p.Glu997fs)	VPS13B	E997fs	Cohen syndrome	Pathogenic(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001075321	8	100403838 - 100403839	8	99391610 - 99391611	1075321	1061461		NC_000008.11:99391610:G:GG
NM_152564.5(VPS13B):c.6625dup (p.Ile2209fs)	VPS13B	I2209fs, I2234fs	Cohen syndrome	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001073138	8	100729564 - 100729565	8	99717336 - 99717337	1073138	1061472		NC_000008.11:99717336:AAAAA:AAAAAA
NC_000008.10:g.(?_100443755)_(100443902_?)dup	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001067844	8	100443755 - 100443902			1067844	1054436		
NC_000008.10:g.(?_100396426)_(100479872_?)dup	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, single submitter	VCV001066497	8	100396426 - 100479872			1066497	1054435		
NM_152564.5(VPS13B):c.6962_6963delinsCG (p.Val2321Ala)	VPS13B	V2321A, V2346A	Cohen syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001009562	8	100733187 - 100733188	8	99720959 - 99720960	1009562	992997		NC_000008.11:99720958:TA:CG
NM_152564.5(VPS13B):c.2441_2450delinsTGTCAGC (p.Ser814_His817delinsMetSerAla)	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000971728	8	100205211 - 100205220	8	99192983 - 99192992	971728	955548		NC_000008.11:99192982:GTTGGTCTCA:TGTCAGC
NM_152564.5(VPS13B):c.4946_4947delinsAA (p.Ser1649Lys)	VPS13B	S1649K, S1674K	Cohen syndrome	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV000963380	8	100568878 - 100568879	8	99556650 - 99556651	963380	946260		NC_000008.11:99556649:GC:AA
NM_152564.5(VPS13B):c.9391_9396dup (p.Met3131_Lys3132dup)	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Apr 28, 2019)	criteria provided, single submitter	VCV000945048	8	100844656 - 100844657	8	99832428 - 99832429	945048	925298		NC_000008.11:99832428:ATGAAA:ATGAAAATGAAA
NM_152564.5(VPS13B):c.2527_2528insT (p.Lys843fs)	VPS13B	K843fs	Cohen syndrome	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000943738	8	100286437 - 100286438	8	99274209 - 99274210	943738	934460		NC_000008.11:99274209::T
NM_152564.5(VPS13B):c.11839_11842dup (p.Ser3948fs)	VPS13B	S3973fs, S3948fs	Cohen syndrome	Uncertain significance(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000861389	8	100887737 - 100887738	8	99875509 - 99875510	861389	835280		NC_000008.11:99875509:TTCTT:TTCTTTCTT
NM_152564.5(VPS13B):c.5540dup (p.Ser1848fs)	VPS13B	S1848fs, S1873fs	Cohen syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000848471	8	100654356 - 100654357	8	99642128 - 99642129	848471	835223		NC_000008.11:99642128:AA:AAA
NM_152564.5(VPS13B):c.5244dup (p.Val1749fs)	VPS13B	V1749fs, V1774fs	not provided|Cohen syndrome	Pathogenic(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000845268	8	100654056 - 100654057	8	99641828 - 99641829	845268	835219		NC_000008.11:99641828:AAAAAA:AAAAAAA
NC_000008.11:g.(?_99766774)_(99784476_?)dup	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000833160	8	100779002 - 100796704			833160	820029		
NC_000008.11:g.(?_99013769)_(99875686_?)dup	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000833046	8	100025997 - 100887914			833046	820004		
NC_000008.11:g.(?_99192876)_(99209768_?)dup	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000833031	8	100205104 - 100221996			833031	820017		
NC_000008.11:g.(?_99134631)_(99511512_?)dup	VPS13B		Cohen syndrome	Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000831712	8	100146859 - 100523740			831712	820012		
NC_000008.11:g.(?_99013769)_(99038586_?)dup	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000831558	8	100025997 - 100050814			831558	820002		
NM_152564.5(VPS13B):c.7429+14dup	VPS13B		Cohen syndrome	Benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV000745210	8	100789190 - 100789191	8	99776962 - 99776963	745210	759717	rs747441995	NC_000008.11:99776962:TTTTTTTT:TTTTTTTTT
NM_152564.5(VPS13B):c.5533dup (p.Thr1845fs)	VPS13B	T1845fs, T1870fs	Cohen syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000645667	8	100654345 - 100654346	8	99642117 - 99642118	645667	637523	rs1176397159	NC_000008.11:99642117:AAAAAA:AAAAAAA
NM_152564.5(VPS13B):c.4302_4304dup (p.Lys1434dup)	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000645286	8	100523405 - 100523406	8	99511177 - 99511178	645286	637511	rs1297058561	NC_000008.11:99511177:AAAAAA:AAAAAAAAA
NM_152564.5(VPS13B):c.581-9dup	VPS13B		Cohen syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000592378	8	100123308 - 100123309	8	99111080 - 99111081	592378	583415	rs60664170	NC_000008.11:99111080:TTTTTTTTT:TTTTTTTTTT
NC_000008.10:g.(?_100025997)_(100133735_?)dup	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000584153	8	100025997 - 100133735	8	99013769 - 99121507	584153	561864		
NM_152564.5(VPS13B):c.9293_9295dup (p.Pro3098dup)	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000578538	8	100836166 - 100836167	8	99823938 - 99823939	578538	565305	rs1182385860	NC_000008.11:99823938:ACCAC:ACCACCAC
NM_152564.5(VPS13B):c.1334_1335delinsTT (p.Cys445Phe)	VPS13B	C445F	Cohen syndrome	Uncertain significance(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000571025	8	100147274 - 100147275	8	99135046 - 99135047	571025	565283	rs1563560499	NC_000008.11:99135045:GC:TT
NM_152564.5(VPS13B):c.11338dup (p.Val3780fs)	VPS13B	V3805fs, V3780fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557835	8	100880634 - 100880635	8	99868406 - 99868407	557835	544985	rs1554586953	NC_000008.11:99868406:GGGGG:GGGGGG
NM_152564.5(VPS13B):c.4224+698dup	VPS13B	F1431fs	Cohen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 17, 2020)	criteria provided, conflicting interpretations	VCV000556421	8	100520127 - 100520128	8	99507899 - 99507900	556421	544923	rs1427643616	NC_000008.11:99507899:TT:TTT
NM_152564.5(VPS13B):c.11967_11970dup (p.Ala3991Ter)	VPS13B	A3991*, A4016*	Cohen syndrome|not provided	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555840	8	100887863 - 100887864	8	99875635 - 99875636	555840	545015	rs769983613	NC_000008.11:99875635:AAATAAA:AAATAAATAAA
NM_152564.5(VPS13B):c.5154delinsCC (p.Gln1719fs)	VPS13B	Q1719fs, Q1744fs	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550106	8	100589795	8	99577567	550106	545013	rs1554853667	NC_000008.11:99577566:T:CC
NM_017890.4(VPS13B):c.9850dup (p.Ile3284Asnfs)	VPS13B	I3259fs, I3284fs	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000498787	8	100847792 - 100847793	8	99835564 - 99835565	498787	490211	rs774357106	NC_000008.11:99835564:AAAAAAA:AAAAAAAA
NM_152564.5(VPS13B):c.816dup (p.Met273fs)	VPS13B	M273fs	not provided|Cohen syndrome	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000450634	8	100127980 - 100127981	8	99115752 - 99115753	450634	444313	rs1554622647	NC_000008.11:99115752:T:TT
NM_152564.5(VPS13B):c.3445+7_3445+9dup	VPS13B		Cohen syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)	criteria provided, conflicting interpretations	VCV000448876	8	100454868 - 100454869	8	99442640 - 99442641	448876	441247	rs1335342521	NC_000008.11:99442640:TGTT:TGTTGTT
NM_152564.5(VPS13B):c.5772dup (p.Gln1925fs)	VPS13B	Q1925fs, Q1950fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371482	8	100654589 - 100654590	8	99642361 - 99642362	371482	357706	rs754016783	NC_000008.11:99642361:A:AA
NM_152564.5(VPS13B):c.3027_3045dup (p.Tyr1016delinsIleIleSerGlyLeuTer)	VPS13B		Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370665	8	100403875 - 100403876	8	99391647 - 99391648	370665	357694	rs1057516670	NC_000008.11:99391647:AATCATATCAGGCCTCTGAA:AATCATATCAGGCCTCTGAAATCATATCAGGCCTCTGAA
NM_152564.5(VPS13B):c.*1504_*1507dup	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361121	8	100889396 - 100889397	8	99877168 - 99877169	361121	310310	rs747583708	NC_000008.11:99877168:TCTTT:TCTTTCTTT
NM_152564.5(VPS13B):c.*1106_*1108dup	VPS13B		Cohen syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361115	8	100888998 - 100888999	8	99876770 - 99876771	361115	306182	rs765534822	NC_000008.11:99876770:TGAT:TGATGAT
NM_152564.5(VPS13B):c.*702dup	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361109	8	100888595 - 100888596	8	99876367 - 99876368	361109	310298	rs200421894	NC_000008.11:99876367:T:TT
NM_152564.5(VPS13B):c.*597_*598dup	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361107	8	100888489 - 100888490	8	99876261 - 99876262	361107	310296	rs397791669	NC_000008.11:99876261:TTT:TTTTT
NM_152564.5(VPS13B):c.*336_*353dup	VPS13B		Cohen syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361104	8	100888229 - 100888230	8	99876001 - 99876002	361104	315730	rs554420171	NC_000008.11:99876001:ACAGGGCCCTATATGTTC:ACAGGGCCCTATATGTTCACAGGGCCCTATATGTTC
NM_152564.5(VPS13B):c.*250_*252dup	VPS13B		Cohen syndrome|not provided	Benign/Likely benign(Last reviewed: Jul 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000361101	8	100888141 - 100888142	8	99875913 - 99875914	361101	315548	rs71274940	NC_000008.11:99875913:CAACA:CAACAACA
NM_152564.5(VPS13B):c.*33_*36dup	VPS13B		Cohen syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000361098	8	100887925 - 100887926	8	99875697 - 99875698	361098	315716	rs373852425	NC_000008.11:99875697:TGATT:TGATTGATT
NM_152564.5(VPS13B):c.9718dup (p.Met3240fs)	VPS13B	M3265fs, M3240fs	Cohen syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279782	8	100847523 - 100847524	8	99835295 - 99835296	279782	264452	rs886041185	NC_000008.11:99835295:AAAAA:AAAAAA
NM_152564.5(VPS13B):c.11705_11709delinsAGAA (p.Thr3902fs)	VPS13B	T3902fs, T3927fs	Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189182	8	100883885 - 100883889	8	99871657 - 99871661	189182	186773	rs386834067	NC_000008.11:99871656:CAGTG:AGAA
NM_152564.5(VPS13B):c.5259dup (p.Gly1754fs)	VPS13B	G1779fs, G1754fs	not provided|Cohen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188881	8	100654076 - 100654077	8	99641848 - 99641849	188881	186772	rs786204533	NC_000008.11:99641848:T:TT
NM_152564.5(VPS13B):c.11831_11841delinsG (p.Pro3944fs)	VPS13B	P3944fs, P3969fs	not provided|Cohen syndrome	Likely pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188770	8	100887731 - 100887741	8	99875503 - 99875513	188770	186774	rs786204456	NC_000008.11:99875502:CCAGCTGTTCT:G
NM_152564.5(VPS13B):c.5908+2dup	VPS13B		Cohen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000132794	8	100654727 - 100654728	8	99642499 - 99642500	132794	136543	rs587777381	NC_000008.11:99642499:T:TT
NM_152564.5(VPS13B):c.6455-4dup	VPS13B		History of neurodevelopmental disorder|not provided|Cohen syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095861	8	100729386 - 100729387	8	99717158 - 99717159	95861	101758	rs398124337	NC_000008.11:99717158:TTTTTTTTT:TTTTTTTTTT
NM_152564.5(VPS13B):c.5662dup (p.Ile1888fs)	VPS13B	I1888fs, I1913fs	Cohen syndrome	Pathogenic(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000056676	8	100654473 - 100654474	8	99642245 - 99642246	56676	71315	rs386834096	NC_000008.11:99642245:AAAAAAA:AAAAAAAA
NM_152564.5(VPS13B):c.5386dup (p.Arg1796fs)	VPS13B	R1796fs, R1821fs	Cohen syndrome|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056674	8	100654201 - 100654202	8	99641973 - 99641974	56674	71313	rs180177364	NC_000008.11:99641973:CCC:CCCC
NM_152564.5(VPS13B):c.4803_4805dup (p.Tyr1602Ter)	VPS13B	Y1627*, Y1602*	Cohen syndrome|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056670	8	100568733 - 100568734	8	99556505 - 99556506	56670	71309	rs180177359	NC_000008.11:99556505:AATA:AATAATA
NM_152564.5(VPS13B):c.404dup (p.Leu135fs)	VPS13B	L135fs	not provided|Cohen syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000056661	8	100108650 - 100108651	8	99096422 - 99096423	56661	71300	rs386834083	NC_000008.11:99096422:TT:TTT
NM_152564.5(VPS13B):c.2727_2730dup (p.Asn911fs)	VPS13B	N911fs	Cohen syndrome|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056654	8	100287384 - 100287385	8	99275156 - 99275157	56654	71293	rs180177357	NC_000008.11:99275156:GCTC:GCTCGCTC
NM_152564.5(VPS13B):c.11832dup (p.Ser3945fs)	VPS13B	S3945fs, S3970fs	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056644	8	100887727 - 100887728	8	99875499 - 99875500	56644	71283	rs180177374	NC_000008.11:99875499:CCCCC:CCCCCC
NM_152564.5(VPS13B):c.11750_11752dup (p.Asp3917dup)	VPS13B		Cohen syndrome|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2021)	criteria provided, conflicting interpretations	VCV000056642	8	100887648 - 100887649	8	99875420 - 99875421	56642	71281	rs386834068	NC_000008.11:99875420:GATG:GATGATG
NM_152564.5(VPS13B):c.10081dup (p.Thr3361fs)	VPS13B	T3386fs, T3361fs	Cohen syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056629	8	100865697 - 100865698	8	99853469 - 99853470	56629	71268	rs386834055	NC_000008.11:99853469:A:AA
NM_152564.5(VPS13B):c.9185dup (p.Leu3062fs)	VPS13B	L3062fs, L3087fs	Cohen syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jan 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002826	8	100836059 - 100836060	8	99823831 - 99823832	2826	17865	rs180177329	NC_000008.11:99823831:TT:TTT
NM_006005.3(WFS1):c.1107_1108insA (p.Ala370fs)	WFS1	A370fs	Wolfram syndrome 1	Pathogenic	criteria provided, single submitter	VCV001264330	4	6302629 - 6302630	4	6300902 - 6300903	1264330	1254231		NC_000004.12:6300902::A
NM_006005.3(WFS1):c.2224dup (p.Cys742fs)	WFS1	C742fs	Wolfram syndrome 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000807719	4	6303745 - 6303746	4	6302018 - 6302019	807719	798545	rs1578612324	NC_000004.12:6302018:T:TT
NM_006005.3(WFS1):c.1441_1447dup (p.Val483fs)	WFS1	V483fs	Rare genetic deafness	Pathogenic(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	VCV000166564	4	6302962 - 6302963	4	6301235 - 6301236	166564	176920	rs727503745	NC_000004.12:6301235:CTGAAGG:CTGAAGGCTGAAGG
NM_006005.3(WFS1):c.409_424dup (p.Val142fs)	WFS1	V142fs	not provided|Wolfram syndrome|Type 2 diabetes mellitus|WFS1-Related Spectrum Disorders|Wolfram syndrome 1	Pathogenic(Last reviewed: Jun 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004519	4	6290805 - 6290806	4	6289078 - 6289079	4519	19558	rs1362648752	NC_000004.12:6289078:GGGCCGTCGCGAGGCTG:GGGCCGTCGCGAGGCTGGGCCGTCGCGAGGCTG
WFS1, 7-BP INS, NT1610	WFS1		Wolfram syndrome 1	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000004513					4513	19552		
NM_015404.4(WHRN):c.*325dup	WHRN		Nonsyndromic Hearing Loss, Recessive|Retinitis pigmentosa-deafness syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000364673	9	117164708 - 117164709	9	114402428 - 114402429	364673	316100	rs886063369	NC_000009.12:114402428:GGGGGG:GGGGGGG
NM_018979.4(WNK1):c.1089_1090insT (p.Val364fs)	WNK1	V364fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637916	12	936364 - 936365	12	827198 - 827199	637916	625284	rs1591884532	NC_000012.12:827198::T
NM_018979.4(WNK1):c.918_919insA (p.Gly307fs)	WNK1	G307fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637898	12	922966 - 922967	12	813800 - 813801	637898	625282	rs1591818480	NC_000012.12:813800::A
NM_018979.4(WNK1):c.1137dup (p.Ala380fs)	WNK1	A380fs	Charcot-Marie-Tooth disease	Uncertain significance	no assertion criteria provided	VCV000637897	12	936408 - 936409	12	827242 - 827243	637897	625285	rs1591884667	NC_000012.12:827242:TTTT:TTTTT
NM_003680.4(YARS1):c.1281dup (p.Pro428fs)	YARS1	P428fs	Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000970902	1	33245738 - 33245739	1	32780137 - 32780138	970902	952389		NC_000001.11:32780137:TTT:TTTT
NC_000001.11:g.(?_32775971)_(32797853_?)dup	YARS1		Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000830933	1	33241572 - 33263454			830933	818963		
NM_003680.4(YARS1):c.739_740delinsGC (p.Lys247Ala)	YARS1	K247A	Charcot-Marie-Tooth disease, dominant intermediate C	Uncertain significance(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000464879	1	33252621 - 33252622	1	32787020 - 32787021	464879	447801	rs1553123307	NC_000001.11:32787019:TT:GC
NM_003680.4(YARS1):c.241_242delinsAT (p.Asp81Ile)	YARS1	D81I	Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000187863	1	33276330 - 33276331	1	32810729 - 32810730	187863	185755	rs786204003	NC_000001.11:32810728:TC:AT
NM_017757.3(ZNF407):c.2814_2816dup (p.Val939dup)	ZNF407		Short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies|Neurodevelopmental delay	Pathogenic(Last reviewed: Oct 1, 2021)	no assertion criteria provided	VCV000545668	18	72345788 - 72345789	18	74633832 - 74633833	545668	536164	rs1568135082	NC_000018.10:74633832:AGT:AGTAGT
